cid,cmpdname,cmpdsynonym,mw,mf,polararea,complexity,xlogp,heavycnt,hbonddonor,hbondacc,rotbonds,inchi,isosmiles,inchikey,iupacname,meshheadings,annothits,annothitcnt,aids,cidcdate,sidsrcname,depcatg,annotation
139291005,PROTAC ERRalpha ligand 2,"PROTAC ERRalpha ligand 2|CHEMBL4514580|2306388-57-6|(E)-3-(4-((2,4-Bis(trifluoromethyl)benzyl)oxy)-3-methoxyphenyl)-2-cyanoacrylic acid|PROTAC ERR|A ligand 2|EX-A5031|BDBM50501971|MFCD32215326|HY-126351|CS-0102786",445.3,C20H13F6NO4,79.6,711,5,31,1,11,6,"InChI=1S/C20H13F6NO4/c1-30-17-7-11(6-13(9-27)18(28)29)2-5-16(17)31-10-12-3-4-14(19(21,22)23)8-15(12)20(24,25)26/h2-8H,10H2,1H3,(H,28,29)/b13-6+",COC1=C(C=CC(=C1)/C=C(\\C#N)/C(=O)O)OCC2=C(C=C(C=C2)C(F)(F)F)C(F)(F)F,JRWKJGIKIBTXMV-AWNIVKPZSA-N,"(E)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyanoprop-2-enoic acid",NULL,Classification|Patents,2,NULL,20191031,A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Ambeed|BenchChem|BindingDB|Chem-Space.com Database|ChEMBL|CSNpharm|DC Chemicals|Excenen Pharmatech|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
135156947,Gefitinib-based PROTAC 3,"Gefitinib-based PROTAC 3|2230821-27-7|PROTAC 3|CHEMBL4587573|SCHEMBL20305518|GTPL10636|EX-A3010|NTN21277|AKOS037653377|HY-123921|CS-0087480|S0070|(2S,4R)-1-((S)-2-(3-(2-((5-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)pentyl)oxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide",934.5,C47H57ClFN7O8S,215,1480,6.9,65,4,14,23,"InChI=1S/C47H57ClFN7O8S/c1-29-42(65-28-53-29)31-11-9-30(10-12-31)25-50-45(59)38-22-33(57)26-56(38)46(60)43(47(2,3)4)55-41(58)15-18-63-20-19-62-16-7-6-8-17-64-40-23-34-37(24-39(40)61-5)51-27-52-44(34)54-32-13-14-36(49)35(48)21-32/h9-14,21,23-24,27-28,33,38,43,57H,6-8,15-20,22,25-26H2,1-5H3,(H,50,59)(H,55,58)(H,51,52,54)/t33-,38+,43-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCOCCOCCCCCOC4=C(C=C5C(=C4)C(=NC=N5)NC6=CC(=C(C=C6)F)Cl)OC)O,NICKHWYZMNLEPJ-TZSMONEZSA-N,"(2S,4R)-1-[(2S)-2-[3-[2-[5-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypentoxy]ethoxy]propanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,Classification|Literature|Patents,3,NULL,20181215,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|Chem-Space.com Database|ChEMBL|eNovation Chemicals|Excenen Pharmatech|IUPHAR/BPS Guide to PHARMACOLOGY|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Selleck Chemicals|SureChEMBL|TargetMol (Target Molecule Corp.)|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
132472236,Cdk9-protac,"CDK9-PROTAC|PROTAC CDK9 Degrader-1|2118356-96-8|N-(5-Cyclobutyl-1H-pyrazol-3-yl)-2-(4-((5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)pentyl)oxy)phenyl)acetamide|CHEMBL4519788|SCHEMBL21691024|AKOS037653368|HY-103628|CS-0028478",613.7,C33H35N5O7,160,1110,3.4,45,3,8,13,"InChI=1S/C33H35N5O7/c39-28-15-14-25(31(41)35-28)38-32(42)23-8-5-9-26(30(23)33(38)43)45-17-3-1-2-16-44-22-12-10-20(11-13-22)18-29(40)34-27-19-24(36-37-27)21-6-4-7-21/h5,8-13,19,21,25H,1-4,6-7,14-18H2,(H,35,39,41)(H2,34,36,37,40)",C1CC(C1)C2=CC(=NN2)NC(=O)CC3=CC=C(C=C3)OCCCCCOC4=CC=CC5=C4C(=O)N(C5=O)C6CCC(=O)NC6=O,WCEHIDWONYOKOJ-UHFFFAOYSA-N,"N-(5-cyclobutyl-1H-pyrazol-3-yl)-2-[4-[5-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxypentoxy]phenyl]acetamide",NULL,Classification|Patents,2,NULL,20180329,AbaChemScene|AKos Consulting & Solutions|BOC Sciences|Chem-Space.com Database|ChEMBL|CSNpharm|DC Chemicals|eNovation Chemicals|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL|TargetMol (Target Molecule Corp.)|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
135397670,PROTAC Sirt2 Degrader-1,"Sirt2-PROTAC-1|PROTAC Sirt2 Degrader-1|2098487-75-1|CHEMBL4225467|2-((4,6-Dimethylpyrimidin-2-yl)thio)-N-(5-(3-((1-(4-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)butyl)-1H-1,2,3-triazol-4-yl)methoxy)benzyl)thiazol-2-yl)acetamide|BDBM50459841|AKOS037653400|HY-103636|CS-0028486",852.9,C40H40N10O8S2,283,1540,3.2,60,3,15,18,"InChI=1S/C40H40N10O8S2/c1-23-15-24(2)44-40(43-23)59-22-34(53)46-39-42-18-28(60-39)17-25-7-5-8-27(16-25)57-20-26-19-49(48-47-26)14-4-3-13-41-33(52)21-58-31-10-6-9-29-35(31)38(56)50(37(29)55)30-11-12-32(51)45-36(30)54/h5-10,15-16,18-19,30H,3-4,11-14,17,20-22H2,1-2H3,(H,41,52)(H,42,46,53)(H,45,51,54)",CC1=CC(=NC(=N1)SCC(=O)NC2=NC=C(S2)CC3=CC(=CC=C3)OCC4=CN(N=N4)CCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)C,GRYRXFYWVDWPQY-UHFFFAOYSA-N,"N-[4-[4-[[3-[[2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]amino]-1,3-thiazol-5-yl]methyl]phenoxy]methyl]triazol-1-yl]butyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide",NULL,Biological Test Results|Classification|Biological Test Results: Active|Biological Test Results: Micromolar,4,1387857|1387858|1387859|1387860|1387861|1387862|1387864|1387865|1387866|1387867,20181227,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BindingDB|BOC Sciences|Chem-Space.com Database|ChEMBL|CSNpharm|DC Chemicals|eNovation Chemicals|MedChemexpress MCE|MolPort|Smolecule|THE BioTek,Chemical Vendors|Curation Efforts|Research and Development,NULL
138911382,PROTAC ERRalpha Degrader-2,PROTAC ERRalpha Degrader-2|PROTAC ERR|A Degrader-2|2306388-85-0|HY-128839|CS-0100634,1151,C57H55Cl2F6N7O8,175,2190,10.3,80,2,16,20,"InChI=1S/C57H55Cl2F6N7O8/c1-34(2)80-47-29-43(77-3)19-20-44(47)53-69-51(36-10-15-41(58)16-11-36)52(37-12-17-42(59)18-13-37)72(53)55(76)71-25-24-70(50(74)32-71)31-49(73)67-22-6-5-7-23-68-54(75)39(30-66)26-35-8-21-46(48(27-35)78-4)79-33-38-9-14-40(56(60,61)62)28-45(38)57(63,64)65/h8-21,26-29,34,51-52H,5-7,22-25,31-33H2,1-4H3,(H,67,73)(H,68,75)/b39-26+/t51-,52+/m1/s1",CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCN(C(=O)C3)CC(=O)NCCCCCNC(=O)/C(=C/C4=CC(=C(C=C4)OCC5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)OC)/C#N)C6=CC=C(C=C6)Cl)C7=CC=C(C=C7)Cl,BCMRBUQELZGQDK-ZAZFVFGXSA-N,"(E)-N-[5-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]pentyl]-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyanoprop-2-enamide",NULL,NULL,0,NULL,20190902,AbaChemScene|BLD Pharm|MedChemexpress MCE,Chemical Vendors,NULL
139035014,SMARCA-BD ligand 1 for Protac dihydrochloride,SMARCA-BD ligand 1 for Protac (dihydrochloride)|HY-44012A|CS-0102910|SMARCA-BD ligand 1 for Protac dihydrochloride|2369053-68-7,344.2,C14H19Cl2N5O,87.3,310,NULL,22,5,6,2,"InChI=1S/C14H17N5O.2ClH/c15-14-12(19-7-5-16-6-8-19)9-11(17-18-14)10-3-1-2-4-13(10)20;;/h1-4,9,16,20H,5-8H2,(H2,15,18);2*1H",C1CN(CCN1)C2=CC(=NN=C2N)C3=CC=CC=C3O.Cl.Cl,INBBYNMFULAIMY-UHFFFAOYSA-N,2-(6-amino-5-piperazin-1-ylpyridazin-3-yl)phenol;dihydrochloride,NULL,NULL,NA,NULL,20190930,A2B Chem|AA BLOCKS|AbaChemScene|BenchChem|Chem-Space.com Database|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.),Chemical Vendors|Legacy Depositors,NULL
134160245,Protac linker 5,"Protac linker 5|2245697-83-8|(S,R,S)-AHPC-C4-NH2 (hydrochloride)|VH 032 Linker 3|BCP33413|EX-A3911|AKOS034834082|(S,R,S)-AHPC-C4-NH2 hydrochloride|E3 ligase Ligand-Linker Conjugates 28|HY-114176|CS-0078575|(2S,4R)-1-((S)-2-(5-aminopentanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride|(S,R,S)-AHPC-C4-NH2 HCl;VH032-C4-NH2 hydrochloride; VHL Ligand-Linker Conjugates 13; Protac linker 5;E3 ligase Ligand-Linker Conjugates 28",566.2,C27H40ClN5O4S,166,783,NULL,38,5,7,11,"InChI=1S/C27H39N5O4S.ClH/c1-17-23(37-16-30-17)19-10-8-18(9-11-19)14-29-25(35)21-13-20(33)15-32(21)26(36)24(27(2,3)4)31-22(34)7-5-6-12-28;/h8-11,16,20-21,24,33H,5-7,12-15,28H2,1-4H3,(H,29,35)(H,31,34);1H/t20-,21+,24-;/m1./s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCN)O.Cl,HJICCZROGLAHNB-BIBCNAKVSA-N,"(2S,4R)-1-[(2S)-2-(5-aminopentanoylamino)-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;hydrochloride",NULL,NULL,NA,NULL,20180620,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|BioChemPartner|Chem-Space.com Database|ChemShuttle|DC Chemicals|Excenen Pharmatech|MedChemexpress MCE|MolPort|Tenova Pharmaceuticals Inc,Chemical Vendors,NULL
138911381,PROTAC ERRalpha Degrader-1,"PROTAC ERRalpha Degrader-1|2306388-84-9|ERRalpha Degrader-1|PROTAC ERR|A Degrader-1|HY-128838|CS-0100633|(E)-N-(2-(2-(4-((4R,5S)-4,5-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydro-1H-imidazole-1-carbonyl)-2-oxopiperazin-1-yl)acetamido)ethyl)-3-(4-((2,4-bis(trifluoromethyl)benzyl)oxy)-3-methoxyphenyl)-2-cyanoacrylamide",1108.9,C54H49Cl2F6N7O8,175,2130,9.3,77,2,16,17,"InChI=1S/C54H49Cl2F6N7O8/c1-31(2)77-44-26-40(74-3)16-17-41(44)50-66-48(33-7-12-38(55)13-8-33)49(34-9-14-39(56)15-10-34)69(50)52(73)68-22-21-67(47(71)29-68)28-46(70)64-19-20-65-51(72)36(27-63)23-32-5-18-43(45(24-32)75-4)76-30-35-6-11-37(53(57,58)59)25-42(35)54(60,61)62/h5-18,23-26,31,48-49H,19-22,28-30H2,1-4H3,(H,64,70)(H,65,72)/b36-23+/t48-,49+/m1/s1",CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCN(C(=O)C3)CC(=O)NCCNC(=O)/C(=C/C4=CC(=C(C=C4)OCC5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)OC)/C#N)C6=CC=C(C=C6)Cl)C7=CC=C(C=C7)Cl,ZVQCWVLBPYOZNC-XNCCLBLBSA-N,"(E)-N-[2-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]ethyl]-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyanoprop-2-enamide",NULL,NULL,0,NULL,20190902,AbaChemScene|BLD Pharm|MedChemexpress MCE|THE BioTek,Chemical Vendors,NULL
46218170,PROTAC CRABP-II Degrader-2,PROTAC CRABP-II Degrader-2|CHEMBL2048499|AKOS037653380|HY-111841|CS-0093180,809,C44H64N4O10,208,1520,3.6,58,5,12,26,"InChI=1S/C44H64N4O10/c1-30(2)26-38(47-42(53)41(52)36(45)28-34-14-9-8-10-15-34)43(54)57-25-24-56-23-22-55-21-20-46-39(49)29-58-48-37-18-19-44(6,7)35(33(37)5)17-16-31(3)12-11-13-32(4)27-40(50)51/h8-17,27,30,36,38,41,52H,18-26,28-29,45H2,1-7H3,(H,46,49)(H,47,53)(H,50,51)/b13-11+,17-16+,31-12+,32-27+,48-37+/t36-,38+,41+/m1/s1",CC\\1=C(C(CC/C1=N\\OCC(=O)NCCOCCOCCOC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](CC2=CC=CC=C2)N)O)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,LJDTZKKSXVIAPQ-FATAJGLMSA-N,"(2E,4E,6E,8E)-9-[(3E)-3-[2-[2-[2-[2-[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]oxyethoxy]ethoxy]ethylamino]-2-oxoethoxy]imino-2,6,6-trimethylcyclohexen-1-yl]-3,7-dimethylnona-2,4,6,8-tetraenoic acid",NULL,Biological Test Results|Classification,2,670302|670307|670308|670309|690787|690797|704677|704693|704694|704695|704696,20100706,AbaChemScene|AKos Consulting & Solutions|ChEMBL|DiscoveryGate|MedChemexpress MCE|Thomson Pharma,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
46218171,PROTAC CRABP-II Degrader-3,PROTAC CRABP-II Degrader-3|AKOS037653389|HY-111842|CS-0093182,853.1,C46H68N4O11,217,1570,3.5,61,5,13,29,"InChI=1S/C46H68N4O11/c1-32(2)28-40(49-44(55)43(54)38(47)30-36-14-9-8-10-15-36)45(56)60-27-26-59-25-24-58-23-22-57-21-20-48-41(51)31-61-50-39-18-19-46(6,7)37(35(39)5)17-16-33(3)12-11-13-34(4)29-42(52)53/h8-17,29,32,38,40,43,54H,18-28,30-31,47H2,1-7H3,(H,48,51)(H,49,55)(H,52,53)/b13-11+,17-16+,33-12+,34-29+,50-39+/t38-,40+,43+/m1/s1",CC\\1=C(C(CC/C1=N\\OCC(=O)NCCOCCOCCOCCOC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](CC2=CC=CC=C2)N)O)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,RZIQIEBBFSSCIQ-KMRDRQGYSA-N,"(2E,4E,6E,8E)-9-[(3E)-3-[2-[2-[2-[2-[2-[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]oxyethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethoxy]imino-2,6,6-trimethylcyclohexen-1-yl]-3,7-dimethylnona-2,4,6,8-tetraenoic acid",NULL,NULL,0,NULL,20100706,AbaChemScene|AKos Consulting & Solutions|DiscoveryGate|MedChemexpress MCE|Thomson Pharma,Chemical Vendors|Journal Publishers|Legacy Depositors|Subscription Services,NULL
117719853,Protac-I,"PROTAC-I|SCHEMBL16267037|(2S,4R)-1-((S)-2-(Tert-butyl)-19-((7R,8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-7-yl)-4-oxo-6,9,12,15-tetraoxa-3-azanonadecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide|(2S,4R)-1-((S)-2-(tert-Butyl)-19-((7R,8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-7-yl)-4-oxo-6,9,12,15-tetraoxa-3-azanonadecanoyl)-4-hydroxy-N-(4-(4-me",947.2,C52H74N4O10S,217,1580,6.4,67,5,12,23,"InChI=1S/C52H74N4O10S/c1-33-47(67-32-54-33)35-11-9-34(10-12-35)29-53-49(61)43-28-39(58)30-56(43)50(62)48(51(2,3)4)55-45(60)31-66-25-24-65-23-22-64-21-20-63-19-7-6-8-36-26-37-27-38(57)13-14-40(37)41-17-18-52(5)42(46(36)41)15-16-44(52)59/h9-14,27,32,36,39,41-44,46,48,57-59H,6-8,15-26,28-31H2,1-5H3,(H,53,61)(H,55,60)/t36-,39-,41-,42+,43+,44+,46-,48-,52+/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOCCOCCCC[C@@H]4CC5=C(C=CC(=C5)O)[C@@H]6[C@@H]4[C@@H]7CC[C@@H]([C@]7(CC6)C)O)O,AMIXLHOERNJPME-NFKZCJKKSA-N,"(2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[4-[(7R,8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-7-yl]butoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,Patents,1,NULL,20160223,Google Patents|IBM|NextMove Software|PATENTSCOPE (WIPO)|SureChEMBL|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
124187630,FKBP12 PROTAC dTAG-13,"FKBP12 PROTAC dTAG-13|dTAG-13|2064175-41-1|CHEMBL4586585|SCHEMBL18376186|GTPL10533|AKOS037653459|HY-114421|CS-0085058|(2S)-(1R)-3-(3,4-dimethoxyphenyl)-1-(2-(2-((6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)hexyl)amino)-2-oxoethoxy)phenyl)propyl 1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate|[(1R)-3-(3,4-dimethoxyphenyl)-1-[2-[2-[6-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyhexylamino]-2-oxoethoxy]phenyl]propyl] (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]",1049.2,C57H68N4O15,224,1930,7.4,76,2,15,27,"InChI=1S/C57H68N4O15/c1-7-37(36-32-47(71-4)52(73-6)48(33-36)72-5)54(65)60-29-14-12-19-41(60)57(68)76-43(25-22-35-23-26-44(69-2)46(31-35)70-3)38-17-10-11-20-42(38)75-34-50(63)58-28-13-8-9-15-30-74-45-21-16-18-39-51(45)56(67)61(55(39)66)40-24-27-49(62)59-53(40)64/h10-11,16-18,20-21,23,26,31-33,37,40-41,43H,7-9,12-15,19,22,24-25,27-30,34H2,1-6H3,(H,58,63)(H,59,62,64)/t37-,40?,41-,43+/m0/s1",CC[C@@H](C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCC3=CC(=C(C=C3)OC)OC)C4=CC=CC=C4OCC(=O)NCCCCCCOC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O,BJFBRLAWLPZOMJ-QHVFGHLPSA-N,"[(1R)-3-(3,4-dimethoxyphenyl)-1-[2-[2-[6-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyhexylamino]-2-oxoethoxy]phenyl]propyl] (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carboxylate",NULL,Literature|Patents,2,NULL,20170218,AbaChemScene|AKos Consulting & Solutions|BenchChem|Chem-Space.com Database|ChEMBL|Chemenu Inc.|eNovation Chemicals|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|MolPort|Nature Chemical Biology|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.)|Tocris Bioscience,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,NULL
137628637,PROTAC BRD9 Degrader-1,"PROTAC BRD9 Degrader-1|2097971-01-0|SCHEMBL21259422|BCP30517|EX-A3889|AKOS037653394|HY-103632|CS-0028482|(Z)-2-(4-(2-(N'-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-N-(4-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)butyl)acetamide",904,C42H45N7O12S2,299,1960,0.8,63,4,14,16,"InChI=1S/C42H45N7O12S2/c1-48-20-27(37-26(40(48)54)19-32(62-37)38(43)46-24-12-16-63(57,58)17-13-24)23-8-10-29(31(18-23)59-2)60-21-34(51)44-14-3-4-15-45-35(52)22-61-30-7-5-6-25-36(30)42(56)49(41(25)55)28-9-11-33(50)47-39(28)53/h5-8,10,18-20,24,28H,3-4,9,11-17,21-22H2,1-2H3,(H2,43,46)(H,44,51)(H,45,52)(H,47,50,53)",CN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=C(C=C4)OCC(=O)NCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)OC,LOLHUPGCPDURJG-UHFFFAOYSA-N,"N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-2-[4-[2-[N'-(1,1-dioxothian-4-yl)carbamimidoyl]-5-methyl-4-oxothieno[3,2-c]pyridin-7-yl]-2-methoxyphenoxy]acetamide",NULL,Patents,1,NULL,20190408,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|BioChemPartner|BOC Sciences|Chem-Space.com Database|ChemShuttle|CSNpharm|Excenen Pharmatech|MedChemexpress MCE|MolPort|SureChEMBL|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,NULL
137704650,Tbk1 protac 1,TBK1 PROTAC 1|2052306-13-3,1093.2,C53H74BrN9O9S,247,1650,7,73,5,15,31,"InChI=1S/C53H74BrN9O9S/c1-36-46(73-35-58-36)38-16-14-37(15-17-38)31-56-49(66)44-30-41(64)33-63(44)51(68)47(53(2,3)4)60-45(65)34-71-28-10-26-69-24-6-7-25-70-27-11-29-72-42-20-18-40(19-21-42)59-52-57-32-43(54)48(61-52)55-22-9-23-62(5)50(67)39-12-8-13-39/h14-21,32,35,39,41,44,47,64H,6-13,22-31,33-34H2,1-5H3,(H,56,66)(H,60,65)(H2,55,57,59,61)/t41-,44+,47-/m0/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@H]3C[C@@H](CN3C(=O)[C@@H](C(C)(C)C)NC(=O)COCCCOCCCCOCCCOC4=CC=C(C=C4)NC5=NC=C(C(=N5)NCCCN(C)C(=O)C6CCC6)Br)O,QMGHHBHPDDAGGO-MJMCVWLSSA-N,"(2R,4S)-1-[(2R)-2-[[2-[3-[4-[3-[4-[[5-bromo-4-[3-[cyclobutanecarbonyl(methyl)amino]propylamino]pyrimidin-2-yl]amino]phenoxy]propoxy]butoxy]propoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,NULL,0,NULL,20190413,DC Chemicals|eNovation Chemicals,Chemical Vendors,NULL
138454750,PROTAC CDK9 degrader-2,PROTAC CDK9 degrader-2|CHEMBL4530229|HY-112811|CS-0065804,748.7,C39H36N6O10,219,1500,3.9,55,4,12,14,"InChI=1S/C39H36N6O10/c46-27-18-29(48)35(36-34(27)28(47)19-30(55-36)22-10-5-4-6-11-22)54-21-23-20-44(43-42-23)17-8-3-1-2-7-14-31(49)40-25-13-9-12-24-33(25)39(53)45(38(24)52)26-15-16-32(50)41-37(26)51/h4-6,9-13,18-20,26,46,48H,1-3,7-8,14-17,21H2,(H,40,49)(H,41,50,51)",C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)CCCCCCCN4C=C(N=N4)COC5=C(C=C(C6=C5OC(=CC6=O)C7=CC=CC=C7)O)O,MRRHEHIWXXJQQL-UHFFFAOYSA-N,"8-[4-[(5,7-dihydroxy-4-oxo-2-phenylchromen-8-yl)oxymethyl]triazol-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]octanamide",NULL,NULL,0,NULL,20190712,AbaChemScene|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
138454782,PROTAC ER Degrader-3,PROTAC ER Degrader-3|AKOS037653388|HY-128527|CS-0095381,1220.4,C71H77N7O12,230,2430,10.7,90,3,13,26,"InChI=1S/C71H77N7O12/c1-10-57(49-16-12-11-13-17-49)64(51-25-30-55(79)31-26-51)52-27-32-56(33-28-52)89-39-37-75(7)63(80)45-88-41-40-87-38-36-73-67(82)53-21-23-54(24-22-53)68(83)78-46(2)65(74-66(81)47(3)76(8)70(85)90-71(4,5)6)69(84)77(60-34-20-48(43-72)42-61(60)78)44-59-58-19-15-14-18-50(58)29-35-62(59)86-9/h11-35,42,46-47,65,79H,10,36-41,44-45H2,1-9H3,(H,73,82)(H,74,81)/b64-57-/t46-,47-,65-/m0/s1",CC/C(=C(\\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C(=O)COCCOCCNC(=O)C3=CC=C(C=C3)C(=O)N4[C@H]([C@@H](C(=O)N(C5=C4C=C(C=C5)C#N)CC6=C(C=CC7=CC=CC=C76)OC)NC(=O)[C@H](C)N(C)C(=O)OC(C)(C)C)C)/C8=CC=CC=C8,ZBSUUCSLUPVKFV-OFHFNDNJSA-N,"tert-butyl N-[(2S)-1-[[(3S,4S)-7-cyano-5-[4-[2-[2-[2-[2-[4-[(Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl-methylamino]-2-oxoethoxy]ethoxy]ethylcarbamoyl]benzoyl]-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-1-oxopropan-2-yl]-N-methylcarbamate",NULL,NULL,0,NULL,20190712,AbaChemScene|AKos Consulting & Solutions|MedChemexpress MCE,Chemical Vendors,NULL
138911386,PROTAC MDM2 Degrader-4,PROTAC MDM2 Degrader-4|HY-128843|CS-0100642,1393.2,C70H74Cl4N8O14,220,2460,10.1,96,0,16,27,"InChI=1S/C70H74Cl4N8O14/c1-43(2)95-57-37-53(89-5)23-25-55(57)67-75-63(45-7-15-49(71)16-8-45)65(47-11-19-51(73)20-12-47)81(67)69(87)79-29-27-77(59(83)39-79)41-61(85)93-35-33-91-31-32-92-34-36-94-62(86)42-78-28-30-80(40-60(78)84)70(88)82-66(48-13-21-52(74)22-14-48)64(46-9-17-50(72)18-10-46)76-68(82)56-26-24-54(90-6)38-58(56)96-44(3)4/h7-26,37-38,43-44,63-66H,27-36,39-42H2,1-6H3/t63-,64-,65+,66+/m0/s1",CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@H]([C@H](N2C(=O)N3CCN(C(=O)C3)CC(=O)OCCOCCOCCOC(=O)CN4CCN(CC4=O)C(=O)N5[C@@H]([C@@H](N=C5C6=C(C=C(C=C6)OC)OC(C)C)C7=CC=C(C=C7)Cl)C8=CC=C(C=C8)Cl)C9=CC=C(C=C9)Cl)C1=CC=C(C=C1)Cl,QEEHXVDZCBZARJ-ADRSHWTGSA-N,"2-[2-[2-[2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]oxyethoxy]ethoxy]ethyl 2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetate",NULL,NULL,0,NULL,20190902,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
138911387,PROTAC CRBN Degrader-1,PROTAC CRBN Degrader-1|HY-128845|CS-0100674,1061.3,C53H72N8O13S,302,1920,3.7,75,6,16,31,"InChI=1S/C53H72N8O13S/c1-34-46(75-33-57-34)36-16-14-35(15-17-36)29-56-48(66)41-28-37(62)30-60(41)52(70)47(53(2,3)4)58-44(65)32-74-25-10-6-8-23-72-27-26-71-22-7-5-9-24-73-31-43(64)55-21-20-54-39-13-11-12-38-45(39)51(69)61(50(38)68)40-18-19-42(63)59-49(40)67/h11-17,33,37,40-41,47,54,62H,5-10,18-32H2,1-4H3,(H,55,64)(H,56,66)(H,58,65)(H,59,63,67)/t37-,40?,41+,47-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCCCCOCCOCCCCCOCC(=O)NCCNC4=CC=CC5=C4C(=O)N(C5=O)C6CCC(=O)NC6=O)O,PEZCAXDTKNFUCR-CTMFSBKBSA-N,"(2S,4R)-1-[(2S)-2-[[2-[5-[2-[5-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethylamino]-2-oxoethoxy]pentoxy]ethoxy]pentoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,NULL,NA,NULL,20190902,AbaChemScene|BenchChem|Chem-Space.com Database|MedChemexpress MCE|MolPort,Chemical Vendors,NULL
139600349,PROTAC BCR-ABL1 ligand 1,PROTAC  BCR-ABL1 ligand 1|SCHEMBL22440783|HY-130297|CS-0106659,347.29,C17H12F3N3O2,67.3,408,4.6,25,2,8,4,"InChI=1S/C17H12F3N3O2/c18-17(19,20)25-14-7-3-12(4-8-14)23-16-9-15(21-10-22-16)11-1-5-13(24)6-2-11/h1-10,24H,(H,21,22,23)",C1=CC(=CC=C1C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F)O,UNNHUSXTCNMGSB-UHFFFAOYSA-N,4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]phenol,NULL,Patents,1,NULL,20191129,AbaChemScene|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
145712388,PROTAC BRD4 degrader for PAC-1,"PROTAC BRD4 degrader for PAC-1|HY-129938|CS-0108575|2417370-39-7|S-(1-(((((3R,5S)-1-((S)-2-(11-(7-(3,5-difluoropyridin-2-yl)-2-methyl-10-((methylsulfonyl)methyl)-3-oxo-3,4,6,7-tetrahydro-2H-2,4,7-triazadibenzo[cd,f]azulene-9-carboxamido)undecanamido)-3,3-dimethylbutanoyl)-5-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)py",1306.6,C62H77F2N9O12S4,347,2740,8.2,89,4,19,29,"InChI=1S/C62H77F2N9O12S4/c1-37-53(86-36-69-37)39-21-19-38(20-22-39)28-68-57(76)49-26-43(85-60(79)84-35-62(5,6)87-89(9,82)83)32-73(49)59(78)54(61(2,3)4)70-50(74)18-16-14-12-10-11-13-15-17-23-65-56(75)44-27-48-45(24-40(44)34-88(8,80)81)46-33-71(7)58(77)52-51(46)41(29-66-52)31-72(48)55-47(64)25-42(63)30-67-55/h19-22,24-25,27,29-30,33,36,43,49,54,66H,10-18,23,26,28,31-32,34-35H2,1-9H3,(H,65,75)(H,68,76)(H,70,74)/t43-,49+,54-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNC(=O)C4=CC5=C(C=C4CS(=O)(=O)C)C6=CN(C(=O)C7=C6C(=CN7)CN5C8=C(C=C(C=N8)F)F)C)OC(=O)OCC(C)(C)SS(=O)(=O)C,SCOQCGGMHFUNNF-FDTYQFAOSA-N,"[(3R,5S)-1-[(2S)-2-[11-[[8-(3,5-difluoropyridin-2-yl)-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carbonyl]amino]undecanoylamino]-3,3-dimethylbutanoyl]-5-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]pyrrolidin-3-yl] (2-methyl-2-methylsulfonylsulfanylpropyl) carbonate",NULL,NULL,NA,NULL,20191231,AbaChemScene|BenchChem|BLD Pharm|MedChemexpress MCE|MolPort,Chemical Vendors,NULL
145925652,CDK ligand for PROTAC,CDK ligand for PROTAC|HY-126534|CS-0105138,494.5,C25H28F2N8O,104,701,1.8,36,3,10,7,"InChI=1S/C25H28F2N8O/c1-15(2)35-20-10-17(9-18(26)24(20)32-22(35)14-36)23-19(27)12-30-25(33-23)31-21-4-3-16(11-29-21)13-34-7-5-28-6-8-34/h3-4,9-12,15,28,36H,5-8,13-14H2,1-2H3,(H,29,30,31,33)",CC(C)N1C2=C(C(=CC(=C2)C3=NC(=NC=C3F)NC4=NC=C(C=C4)CN5CCNCC5)F)N=C1CO,YQMRQLBCUBZXEP-UHFFFAOYSA-N,[4-fluoro-6-[5-fluoro-2-[[5-(piperazin-1-ylmethyl)pyridin-2-yl]amino]pyrimidin-4-yl]-1-propan-2-ylbenzimidazol-2-yl]methanol,NULL,NULL,0,NULL,20200220,AbaChemScene|Chem-Space.com Database|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.),Chemical Vendors|Legacy Depositors,NULL
146478891,PROTAC BRD4 Degrader-7,PROTAC BRD4 Degrader-7|SCHEMBL21846909|HY-136857|CS-0134151,475.6,C26H29N5O2S,124,850,3.5,34,1,7,6,"InChI=1S/C26H29N5O2S/c1-15-16(2)34-25-22(15)23(19-11-9-18(10-12-19)8-7-13-27)28-20(14-21(32)33-26(4,5)6)24-30-29-17(3)31(24)25/h9-12,20H,13-14,27H2,1-6H3/t20-/m0/s1",CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)C#CCN)C,PMSPBUOYDPYDPF-FQEVSTJZSA-N,"tert-butyl 2-[(9S)-7-[4-(3-aminoprop-1-ynyl)phenyl]-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetate",NULL,Patents,1,NULL,20200627,AbaChemScene|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
146673162,PROTAC PD-1/PD-L1 degrader-1,PROTAC PD-1/PD-L1 degrader-1|HY-131183|CS-0130198,1076.6,C59H58ClN7O11,217,2220,6.3,78,2,13,16,"InChI=1S/C59H58ClN7O11/c1-36-40(10-5-11-42(36)39-17-19-48-51(30-39)76-27-26-75-48)35-78-50-31-49(77-34-38-9-4-8-37(28-38)32-61)41(29-44(50)60)33-66-21-3-2-14-47(66)58(73)65-24-22-64(23-25-65)54(70)16-7-15-52(68)62-45-13-6-12-43-55(45)59(74)67(57(43)72)46-18-20-53(69)63-56(46)71/h4-6,8-13,17,19,28-31,46-47H,2-3,7,14-16,18,20-27,33-35H2,1H3,(H,62,68)(H,63,69,71)",CC1=C(C=CC=C1C2=CC3=C(C=C2)OCCO3)COC4=C(C=C(C(=C4)OCC5=CC(=CC=C5)C#N)CN6CCCCC6C(=O)N7CCN(CC7)C(=O)CCCC(=O)NC8=CC=CC9=C8C(=O)N(C9=O)C1CCC(=O)NC1=O)Cl,CJIXMPCTSMEQPG-UHFFFAOYSA-N,"5-[4-[1-[[5-chloro-2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]phenyl]methyl]piperidine-2-carbonyl]piperazin-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]-5-oxopentanamide",NULL,NULL,0,NULL,20200702,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
154824612,PROTAC-VHL-ligand,PROTAC-VHL-ligand,430.6,C22H30N4O3S,137,618,2.4,30,3,7,6,"InChI=1S/C22H30N4O3S/c1-13-18(30-12-24-13)15-7-5-14(6-8-15)10-26-11-16(27)9-17(26)20(28)25-21(29)19(23)22(2,3)4/h5-8,12,16-17,19,27H,9-11,23H2,1-4H3,(H,25,28,29)/t16-,17+,19-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CN3C[C@@H](C[C@H]3C(=O)NC(=O)[C@H](C(C)(C)C)N)O,IPAIGJFOHJDSRN-ZIFCJYIRSA-N,"(2S,4R)-N-[(2S)-2-amino-3,3-dimethylbutanoyl]-4-hydroxy-1-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,NULL,0,NULL,20201128,DC Chemicals,Chemical Vendors,NULL
44582233,Sarm-Nutlin Protac,Sarm-Nutlin Protac|CHEMBL495553,1210,C57H61Cl2F3N8O14,265,2200,6.3,84,4,18,25,"InChI=1S/C57H61Cl2F3N8O14/c1-35(2)84-47-30-43(79-4)18-19-44(47)53-66-51(36-5-9-38(58)10-6-36)52(37-7-11-39(59)12-8-37)69(53)55(75)68-23-22-67(50(73)32-68)31-48(71)63-21-24-80-25-26-81-27-28-82-33-49(72)64-40-13-16-42(17-14-40)83-34-56(3,76)54(74)65-41-15-20-46(70(77)78)45(29-41)57(60,61)62/h5-20,29-30,35,51-52,76H,21-28,31-34H2,1-4H3,(H,63,71)(H,64,72)(H,65,74)/t51-,52+,56+/m1/s1",CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCN(C(=O)C3)CC(=O)NCCOCCOCCOCC(=O)NC4=CC=C(C=C4)OC[C@@](C)(C(=O)NC5=CC(=C(C=C5)[N+](=O)[O-])C(F)(F)F)O)C6=CC=C(C=C6)Cl)C7=CC=C(C=C7)Cl,VKTBFTIPDGAIPC-BIOIQHPWSA-N,"(2S)-3-[4-[[2-[2-[2-[2-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]ethoxy]ethoxy]ethoxy]acetyl]amino]phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide",NULL,Biological Test Results|Literature,2,417067|417068,20100126,ChEMBL,Curation Efforts|Research and Development,NULL
46218079,PROTAC CRABP-II Degrader-1,PROTAC CRABP-II Degrader-1|AKOS037653392|HY-111840|CS-0093179,764.9,C42H60N4O9,199,1470,3.7,55,5,11,23,"InChI=1S/C42H60N4O9/c1-28(2)24-36(45-40(51)39(50)34(43)26-32-14-9-8-10-15-32)41(52)54-23-22-53-21-20-44-37(47)27-55-46-35-18-19-42(6,7)33(31(35)5)17-16-29(3)12-11-13-30(4)25-38(48)49/h8-17,25,28,34,36,39,50H,18-24,26-27,43H2,1-7H3,(H,44,47)(H,45,51)(H,48,49)/b13-11+,17-16+,29-12+,30-25+,46-35+/t34-,36+,39+/m1/s1",CC\\1=C(C(CC/C1=N\\OCC(=O)NCCOCCOC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](CC2=CC=CC=C2)N)O)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,XEMRMMAFXLINDA-XVCXXHFGSA-N,"(2E,4E,6E,8E)-9-[(3E)-3-[2-[2-[2-[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]oxyethoxy]ethylamino]-2-oxoethoxy]imino-2,6,6-trimethylcyclohexen-1-yl]-3,7-dimethylnona-2,4,6,8-tetraenoic acid",NULL,NULL,0,NULL,20100706,AbaChemScene|AKos Consulting & Solutions|DiscoveryGate|MedChemexpress MCE|Thomson Pharma,Chemical Vendors|Journal Publishers|Legacy Depositors|Subscription Services,NULL
90101856,PROTAC Her3-binding moiety 1,"PROTAC Her3-binding moiety 1|SCHEMBL15648086|HY-107444|CS-0028500|3-(3-nitro-4-phenoxyphenyl)-1-(piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine",431.4,C22H21N7O3,137,638,2.9,32,2,8,4,"InChI=1S/C22H21N7O3/c23-21-19-20(27-28(22(19)26-13-25-21)15-8-10-24-11-9-15)14-6-7-18(17(12-14)29(30)31)32-16-4-2-1-3-5-16/h1-7,12-13,15,24H,8-11H2,(H2,23,25,26)",C1CNCCC1N2C3=NC=NC(=C3C(=N2)C4=CC(=C(C=C4)OC5=CC=CC=C5)[N+](=O)[O-])N,IKTNIZXIRAWLRG-UHFFFAOYSA-N,"3-(3-nitro-4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine",NULL,Patents,1,NULL,20150213,AbaChemScene|Google Patents|IBM|MedChemexpress MCE|NextMove Software|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
91799297,PROTAC RIPK degrader-2,"PROTAC_RIPK2|PROTAC RIPK degrader-2|CHEMBL4098772|1801547-16-9|RGN47169|BDBM50246759|HY-111866|CS-0093284|(2S,4R)-1-((S)-17-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinolin-7-yl)oxy)-2-(tert-butyl)-4-oxo-6,9,12,15-tetraoxa-3-azaheptadecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide|(2S,4R)-1-((S)-17-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinolin-7-yl)oxy)-2-(tert-butyl)-4-oxo-6,9,12,15-tetraoxa-3-azaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol",1060.3,C52H65N7O11S3,295,1870,5.9,73,4,17,26,"InChI=1S/C52H65N7O11S3/c1-33-47(72-31-55-33)35-10-8-34(9-11-35)28-54-49(62)42-25-37(60)29-59(42)50(63)48(51(2,3)4)58-46(61)30-69-21-20-67-17-16-66-18-19-68-22-23-70-43-27-40-38(26-45(43)73(64,65)52(5,6)7)39(14-15-53-40)57-36-12-13-44-41(24-36)56-32-71-44/h8-15,24,26-27,31-32,37,42,48,60H,16-23,25,28-30H2,1-7H3,(H,53,57)(H,54,62)(H,58,61)/t37-,42+,48-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOCCOCCOC4=CC5=NC=CC(=C5C=C4S(=O)(=O)C(C)(C)C)NC6=CC7=C(C=C6)SC=N7)O,RIEGJNXDHULIKM-GPPJZCFZSA-N,"(2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[2-[4-(1,3-benzothiazol-5-ylamino)-6-tert-butylsulfonylquinolin-7-yl]oxyethoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,Biological Test Results|Classification|Literature|Biological Test Results: Active|Biological Test Results: Micromolar,5,1471891|1471892,20150608,AbaChemScene|BindingDB|BLD Pharm|ChEMBL|Japan Chemical Substance Dictionary (Nikkaji)|MedChemexpress MCE|MolPort|Nature Chemical Biology|Springer Nature|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development,NULL
131954816,FKBP12 PROTAC dTAG-7,"FKBP12 PROTAC dTAG-7|2064175-32-0|dTAG-7|SCHEMBL20153970|HY-123941|CS-0087588|(1R)-3-(3,4-Dimethoxyphenyl)-1-(2-((19-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2,18-dioxo-7,10,13-trioxa-3,17-diazanonadecyl)oxy)phenyl)propyl (2S)-1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate|(2S)-(1R)-3-(3,4-dimethoxyphenyl)-1-(2-((19-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2,18-dioxo-7,10,13-trioxa-3,17-diazanonadecyl)oxy)phenyl)propyl 1-((S)-2-(3,4,5-trimethoxypheny",1210.3,C63H79N5O19,281,2200,5.5,87,3,19,36,"InChI=1S/C63H79N5O19/c1-7-42(41-36-52(79-4)58(81-6)53(37-41)80-5)60(73)67-28-11-10-17-46(67)63(76)87-48(23-20-40-21-24-49(77-2)51(35-40)78-3)43-15-8-9-18-47(43)85-38-55(70)64-26-13-29-82-31-33-84-34-32-83-30-14-27-65-56(71)39-86-50-19-12-16-44-57(50)62(75)68(61(44)74)45-22-25-54(69)66-59(45)72/h8-9,12,15-16,18-19,21,24,35-37,42,45-46,48H,7,10-11,13-14,17,20,22-23,25-34,38-39H2,1-6H3,(H,64,70)(H,65,71)(H,66,69,72)/t42-,45?,46-,48+/m0/s1",CC[C@@H](C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCC3=CC(=C(C=C3)OC)OC)C4=CC=CC=C4OCC(=O)NCCCOCCOCCOCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O,IFCAWDLUIZXIPI-FJDAOBEISA-N,"[(1R)-3-(3,4-dimethoxyphenyl)-1-[2-[2-[3-[2-[2-[3-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-2-oxoethoxy]phenyl]propyl] (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carboxylate",NULL,Literature|Patents,2,NULL,20180127,AbaChemScene|BLD Pharm|Chem-Space.com Database|Google Patents|MedChemexpress MCE|Nature Chemical Biology|Smolecule|SureChEMBL|TargetMol (Target Molecule Corp.)|Tocris Bioscience,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development,NULL
135172387,PROTAC FLT-3 degrader 1,PROTAC FLT-3 degrader 1|CHEMBL4555872|SCHEMBL20322436|AKOS037653383|HY-114323|CS-0082105,1020.2,C52H61N9O9S2,280,1800,7.7,72,5,14,21,"InChI=1S/C52H61N9O9S2/c1-31-45(71-30-54-31)34-10-8-32(9-11-34)27-53-47(64)40-24-36(62)28-60(40)48(65)46(52(5,6)7)58-44(63)18-19-67-20-21-68-22-23-69-37-16-17-39-41(25-37)72-50-56-38(29-61(39)50)33-12-14-35(15-13-33)55-49(66)57-43-26-42(70-59-43)51(2,3)4/h8-17,25-26,29-30,36,40,46,62H,18-24,27-28H2,1-7H3,(H,53,64)(H,58,63)(H2,55,57,59,66)/t36-,40+,46-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCOCCOCCOC4=CC5=C(C=C4)N6C=C(N=C6S5)C7=CC=C(C=C7)NC(=O)NC8=NOC(=C8)C(C)(C)C)O,IKJBYQODYFQASC-YKCITUTQSA-N,"(2S,4R)-1-[(2S)-2-[3-[2-[2-[2-[4-[(5-tert-butyl-1,2-oxazol-3-yl)carbamoylamino]phenyl]imidazo[2,1-b][1,3]benzothiazol-6-yl]oxyethoxy]ethoxy]propanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,Classification|Patents,2,NULL,20181215,AbaChemScene|AKos Consulting & Solutions|BenchChem|ChEMBL|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
137333441,PROTAC BRD9-binding moiety 1 hydrochloride,PROTAC BRD9-binding moiety 1 hydrochloride|AKOS037653429|HY-107445A|CS-0084716,556.1,C23H26ClN3O7S2,185,980,NULL,36,3,9,7,"InChI=1S/C23H25N3O7S2.ClH/c1-26-11-16(13-3-4-17(18(9-13)32-2)33-12-20(27)28)21-15(23(26)29)10-19(34-21)22(24)25-14-5-7-35(30,31)8-6-14;/h3-4,9-11,14H,5-8,12H2,1-2H3,(H2,24,25)(H,27,28);1H",CN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=C(C=C4)OCC(=O)O)OC.Cl,CHHQBFXRODFSBF-UHFFFAOYSA-N,"2-[4-[2-[N'-(1,1-dioxothian-4-yl)carbamimidoyl]-5-methyl-4-oxothieno[3,2-c]pyridin-7-yl]-2-methoxyphenoxy]acetic acid;hydrochloride",NULL,NULL,NA,NULL,20190227,AbaChemScene|AKos Consulting & Solutions|Chem-Space.com Database|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.),Chemical Vendors|Legacy Depositors,NULL
137628659,Homo-PROTAC cereblon degrader 1,"Homo-PROTAC cereblon degrader 1|2244520-98-5|4,4'-(((Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(azanediyl))bis(2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione)|CHEMBL4435661|EX-A3970|OUN20985|s2881|AKOS037653338|HY-111594|CS-0087832",660.6,C32H32N6O10,210,1260,0.8,48,4,12,13,"InChI=1S/C32H32N6O10/c39-23-9-7-21(27(41)35-23)37-29(43)17-3-1-5-19(25(17)31(37)45)33-11-13-47-15-16-48-14-12-34-20-6-2-4-18-26(20)32(46)38(30(18)44)22-8-10-24(40)36-28(22)42/h1-6,21-22,33-34H,7-16H2,(H,35,39,41)(H,36,40,42)",C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCOCCOCCNC4=CC=CC5=C4C(=O)N(C5=O)C6CCC(=O)NC6=O,OXIPFLHBDVDLDS-UHFFFAOYSA-N,"2-(2,6-dioxopiperidin-3-yl)-4-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethylamino]isoindole-1,3-dione",NULL,Classification,1,NULL,20190408,A2B Chem|AA BLOCKS|AbaChemScene|AbMole Bioscience|AKos Consulting & Solutions|Ambeed|Axon Medchem|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemShuttle|CSNpharm|Excenen Pharmatech|Lan Pharmatech|MedChemexpress MCE|MolPort|Selleck Chemicals|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,NULL
138319681,PROTAC B-Raf degrader 1,PROTAC B-Raf degrader 1|AKOS037653384|HY-111758|CS-0090791|2364367-27-9,763.8,C36H37N5O12S,233,1540,2,54,4,13,15,"InChI=1S/C36H37N5O12S/c1-50-21-15-28(52-3)22(29(16-21)53-4)12-13-54(48,49)19-20-8-10-27(51-2)25(14-20)37-17-31(43)38-18-32(44)39-24-7-5-6-23-33(24)36(47)41(35(23)46)26-9-11-30(42)40-34(26)45/h5-8,10,12-16,26,37H,9,11,17-19H2,1-4H3,(H,38,43)(H,39,44)(H,40,42,45)/b13-12+",COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)NCC(=O)NCC(=O)NC3=CC=CC4=C3C(=O)N(C4=O)C5CCC(=O)NC5=O,AMOFJSISJOOLNX-OUKQBFOZSA-N,"N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-2-oxoethyl]-2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetamide",NULL,NULL,NA,NULL,20190513,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|Chem-Space.com Database|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.),Chemical Vendors|Legacy Depositors,NULL
138454769,PROTAC PARP1 degrader,PROTAC PARP1 degrader|AKOS037653399|HY-114324|CS-0082106,1145.1,C58H63Cl2N11O10,232,2030,5.4,81,2,14,26,"InChI=1S/C58H63Cl2N11O10/c1-38(2)81-50-33-46(76-3)19-20-47(50)57-63-54(40-7-13-43(59)14-8-40)55(41-9-15-44(60)16-10-41)71(57)58(75)68-23-22-67(52(73)37-68)36-51(72)62-21-25-77-27-29-79-31-32-80-30-28-78-26-24-69-35-49(64-66-69)39-11-17-45(18-12-39)70-34-42-5-4-6-48(56(61)74)53(42)65-70/h4-20,33-35,38,54-55H,21-32,36-37H2,1-3H3,(H2,61,74)(H,62,72)/t54-,55+/m1/s1",CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCN(C(=O)C3)CC(=O)NCCOCCOCCOCCOCCN4C=C(N=N4)C5=CC=C(C=C5)N6C=C7C=CC=C(C7=N6)C(=O)N)C8=CC=C(C=C8)Cl)C9=CC=C(C=C9)Cl,RQWKTYKJNCZUJW-OMUYKDLESA-N,"2-[4-[1-[2-[2-[2-[2-[2-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]phenyl]indazole-7-carboxamide",NULL,NULL,0,NULL,20190712,AbaChemScene|AKos Consulting & Solutions|MedChemexpress MCE,Chemical Vendors,NULL
138454783,PROTAC ER Degrader-2,PROTAC ER Degrader-2|HY-128528|CS-0095385,1581.8,C89H104N12O15,358,3250,11,116,7,17,38,"InChI=1S/C89H104N12O15/c1-12-70(61-19-14-13-15-20-61)78(64-33-40-69(41-34-64)115-54-59-24-36-67(37-25-59)95-83(105)73(23-18-44-94-87(92)109)96-84(106)79(91)56(2)3)63-31-38-68(39-32-63)114-48-46-98(9)77(102)55-113-50-49-112-47-45-93-82(104)65-27-29-66(30-28-65)85(107)101-57(4)80(97-81(103)58(5)99(10)88(110)116-89(6,7)8)86(108)100(74-42-26-60(52-90)51-75(74)101)53-72-71-22-17-16-21-62(71)35-43-76(72)111-11/h13-17,19-22,24-43,51,56-58,73,79-80H,12,18,23,44-50,53-55,91H2,1-11H3,(H,93,104)(H,95,105)(H,96,106)(H,",CC/C(=C(/C1=CC=C(C=C1)OCCN(C)C(=O)COCCOCCNC(=O)C2=CC=C(C=C2)C(=O)N3[C@H]([C@@H](C(=O)N(C4=C3C=C(C=C4)C#N)CC5=C(C=CC6=CC=CC=C65)OC)NC(=O)[C@H](C)N(C)C(=O)OC(C)(C)C)C)\\C7=CC=C(C=C7)OCC8=CC=C(C=C8)NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@H](C(C)C)N)/C9=CC=CC=C9,DNJOADSQANNYAY-SCCWQXRBSA-N,"tert-butyl N-[(2S)-1-[[(3S,4S)-5-[4-[2-[2-[2-[2-[4-[(Z)-1-[4-[[4-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methoxy]phenyl]-2-phenylbut-1-enyl]phenoxy]ethyl-methylamino]-2-oxoethoxy]ethoxy]ethylcarbamoyl]benzoyl]-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-1-oxopropan-2-yl]-N-methylcarbamate",NULL,NULL,0,NULL,20190712,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
138727281,PROTAC IRAK4 degrader-1,PROTAC IRAK4 degrader-1|SCHEMBL21106188|HY-129966|CS-0108927,904.9,C44H39F3N12O7,240,1800,3.7,66,5,16,16,"InChI=1S/C44H39F3N12O7/c45-44(46,47)37-31(53-39(62)32-22-66-41(54-32)26-13-15-48-34(17-26)51-18-24-5-6-24)21-58(56-37)28-9-7-25(8-10-28)38(61)49-14-2-16-57-20-27(52-23-57)19-50-30-4-1-3-29-36(30)43(65)59(42(29)64)33-11-12-35(60)55-40(33)63/h1,3-4,7-10,13,15,17,20-24,33,50H,2,5-6,11-12,14,16,18-19H2,(H,48,51)(H,49,61)(H,53,62)(H,55,60,63)",C1CC1CNC2=NC=CC(=C2)C3=NC(=CO3)C(=O)NC4=CN(N=C4C(F)(F)F)C5=CC=C(C=C5)C(=O)NCCCN6C=C(N=C6)CNC7=CC=CC8=C7C(=O)N(C8=O)C9CCC(=O)NC9=O,YXSXFMHKDNIZFS-UHFFFAOYSA-N,"2-[2-(cyclopropylmethylamino)pyridin-4-yl]-N-[1-[4-[3-[4-[[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]methyl]imidazol-1-yl]propylcarbamoyl]phenyl]-3-(trifluoromethyl)pyrazol-4-yl]-1,3-oxazole-4-carboxamide",NULL,Patents,1,NULL,20190720,AbaChemScene|MedChemexpress MCE|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,NULL
138911385,PROTAC MDM2 Degrader-3,PROTAC MDM2 Degrader-3|HY-128842|CS-0100641,1437.2,C72H78Cl4N8O15,230,2520,9.9,99,0,17,30,"InChI=1S/C72H78Cl4N8O15/c1-45(2)98-59-39-55(91-5)23-25-57(59)69-77-65(47-7-15-51(73)16-8-47)67(49-11-19-53(75)20-12-49)83(69)71(89)81-29-27-79(61(85)41-81)43-63(87)96-37-35-94-33-31-93-32-34-95-36-38-97-64(88)44-80-28-30-82(42-62(80)86)72(90)84-68(50-13-21-54(76)22-14-50)66(48-9-17-52(74)18-10-48)78-70(84)58-26-24-56(92-6)40-60(58)99-46(3)4/h7-26,39-40,45-46,65-68H,27-38,41-44H2,1-6H3/t65-,66-,67+,68+/m0/s1",CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@H]([C@H](N2C(=O)N3CCN(C(=O)C3)CC(=O)OCCOCCOCCOCCOC(=O)CN4CCN(CC4=O)C(=O)N5[C@@H]([C@@H](N=C5C6=C(C=C(C=C6)OC)OC(C)C)C7=CC=C(C=C7)Cl)C8=CC=C(C=C8)Cl)C9=CC=C(C=C9)Cl)C1=CC=C(C=C1)Cl,KECKJSNYFPFODX-PINBWVOXSA-N,"2-[2-[2-[2-[2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]oxyethoxy]ethoxy]ethoxy]ethyl 2-[4-[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetate",NULL,NULL,NA,NULL,20190902,AbaChemScene|BenchChem|Chem-Space.com Database|MedChemexpress MCE|MolPort,Chemical Vendors,NULL
139035049,PROTAC SGK3 degrader-1,"PROTAC SGK3 degrader-1|SGK3 degrader-1|EX-A3963|HY-125878|CS-0102619|(2S,4R)-1-((S)-2-(tert-butyl)-18-((R)-2-(((6-(4-(2-fluoro-5-methylphenylsulfonamido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)oxy)methyl)morpholino)-4-oxo-6,9,12-trioxa-3-azaoctadecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide|2381320-35-8",1157.4,C57H73FN10O11S2,298,2050,6,81,5,19,29,"InChI=1S/C57H73FN10O11S2/c1-37-10-19-46(58)48(28-37)81(73,74)66-42-17-15-41(16-18-42)52-63-53-45(31-61-65-53)55(64-52)79-34-44-33-67(21-23-78-44)20-8-6-7-9-22-75-24-25-76-26-27-77-35-49(70)62-51(57(3,4)5)56(72)68-32-43(69)29-47(68)54(71)59-30-39-11-13-40(14-12-39)50-38(2)60-36-80-50/h10-19,28,31,36,43-44,47,51,66,69H,6-9,20-27,29-30,32-35H2,1-5H3,(H,59,71)(H,62,70)(H,61,63,64,65)/t43-,44-,47+,51-/m1/s1",CC1=CC(=C(C=C1)F)S(=O)(=O)NC2=CC=C(C=C2)C3=NC4=C(C=NN4)C(=N3)OC[C@H]5CN(CCO5)CCCCCCOCCOCCOCC(=O)N[C@H](C(=O)N6C[C@@H](C[C@H]6C(=O)NCC7=CC=C(C=C7)C8=C(N=CS8)C)O)C(C)(C)C,RTFQFPZKDYMMMJ-RIAKQDHQSA-N,"(2S,4R)-1-[(2S)-2-[[2-[2-[2-[6-[(2R)-2-[[6-[4-[(2-fluoro-5-methylphenyl)sulfonylamino]phenyl]-1H-pyrazolo[3,4-d]pyrimidin-4-yl]oxymethyl]morpholin-4-yl]hexoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,NULL,NA,NULL,20190930,AbaChemScene|AbMole Bioscience|BenchChem|Chem-Space.com Database|ChemShuttle|Excenen Pharmatech|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.),Chemical Vendors|Legacy Depositors,NULL
139269961,PROTAC ERR(c) paragraph sign ligand 2,BCP32604|PROTAC ERR(c) paragraph sign ligand 2,445.3,C20H13F6NO4,79.6,711,5,31,1,11,6,"InChI=1S/C20H13F6NO4/c1-30-17-7-11(6-13(9-27)18(28)29)2-5-16(17)31-10-12-3-4-14(19(21,22)23)8-15(12)20(24,25)26/h2-8H,10H2,1H3,(H,28,29)",COC1=C(C=CC(=C1)C=C(C#N)C(=O)O)OCC2=C(C=C(C=C2)C(F)(F)F)C(F)(F)F,JRWKJGIKIBTXMV-UHFFFAOYSA-N,"3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyanoprop-2-enoic acid",NULL,NULL,0,NULL,20191029,BioChemPartner,Chemical Vendors,NULL
142572767,PROTAC BRD4 ligand-1,PROTAC BRD4 ligand-1|HY-129939|CS-0108581|2313230-51-0,500.5,C23H18F2N4O5S,132,1020,1.2,35,2,9,4,"InChI=1S/C23H18F2N4O5S/c1-28-9-16-15-3-11(10-35(2,33)34)14(23(31)32)5-18(15)29(21-17(25)4-13(24)7-27-21)8-12-6-26-20(19(12)16)22(28)30/h3-7,9,26H,8,10H2,1-2H3,(H,31,32)",CN1C=C2C3=C(C=C(C(=C3)CS(=O)(=O)C)C(=O)O)N(CC4=CNC(=C42)C1=O)C5=C(C=C(C=N5)F)F,BSYGSSMAXOMCQE-UHFFFAOYSA-N,"8-(3,5-difluoropyridin-2-yl)-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxylic acid",NULL,Patents,1,NULL,20191206,A2B Chem|AA BLOCKS|AbaChemScene|BenchChem|Chem-Space.com Database|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|TargetMol (Target Molecule Corp.),Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development,NULL
145712387,PROTAC BRD4 Degrader-3,PROTAC BRD4 Degrader-3|HY-135558|CS-0113470,1098.3,C55H65F2N9O9S2,273,2210,7.1,77,5,15,22,"InChI=1S/C55H65F2N9O9S2/c1-32-48(76-31-61-32)33-16-18-38(19-17-33)75-63-52(70)44-23-37(67)28-66(44)54(72)49(55(2,3)4)62-45(68)15-13-11-9-7-8-10-12-14-20-58-51(69)39-24-43-40(21-34(39)30-77(6,73)74)41-29-64(5)53(71)47-46(41)35(25-59-47)27-65(43)50-42(57)22-36(56)26-60-50/h16-19,21-22,24-26,29,31,37,44,49,59,67H,7-15,20,23,27-28,30H2,1-6H3,(H,58,69)(H,62,68)(H,63,70)/t37-,44-,49+/m0/s1",CC1=C(SC=N1)C2=CC=C(C=C2)ONC(=O)[C@@H]3C[C@@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNC(=O)C4=CC5=C(C=C4CS(=O)(=O)C)C6=CN(C(=O)C7=C6C(=CN7)CN5C8=C(C=C(C=N8)F)F)C)O,NIIZCTGOGSKWQJ-KTDCMLCKSA-N,"8-(3,5-difluoropyridin-2-yl)-N-[11-[[(2S)-1-[(2S,4S)-4-hydroxy-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenoxy]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-11-oxoundecyl]-15-methyl-4-(methylsulfonylmethyl)-14-oxo-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide",NULL,NULL,0,NULL,20191231,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
145925663,PROTAC EED degrader-1,PROTAC EED degrader-1|HY-130614|CS-0109479,1054.2,C55H60FN11O8S,265,1910,6.7,76,5,16,21,"InChI=1S/C55H60FN11O8S/c1-32-40(43-27-60-54(67-30-62-65-51(43)67)59-26-42-41-20-22-74-46(41)18-17-44(42)56)16-10-36(63-32)11-19-47(69)57-21-23-73-38-12-14-39(15-13-38)75-29-48(70)64-50(55(3,4)5)53(72)66-28-37(68)24-45(66)52(71)58-25-34-6-8-35(9-7-34)49-33(2)61-31-76-49/h6-10,12-18,27,30-31,37,45,50,68H,11,19-26,28-29H2,1-5H3,(H,57,69)(H,58,71)(H,59,60)(H,64,70)/t37-,45+,50-/m1/s1",CC1=C(C=CC(=N1)CCC(=O)NCCOC2=CC=C(C=C2)OCC(=O)N[C@H](C(=O)N3C[C@@H](C[C@H]3C(=O)NCC4=CC=C(C=C4)C5=C(N=CS5)C)O)C(C)(C)C)C6=CN=C(N7C6=NN=C7)NCC8=C(C=CC9=C8CCO9)F,FSFJUWLIBSALJI-FENRPDQVSA-N,"(2S,4R)-1-[(2S)-2-[[2-[4-[2-[3-[5-[5-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methylamino]-[1,2,4]triazolo[4,3-c]pyrimidin-8-yl]-6-methylpyridin-2-yl]propanoylamino]ethoxy]phenoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,NULL,0,NULL,20200220,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
145925664,PROTAC EED degrader-2,PROTAC EED degrader-2|HY-130615|CS-0109486,960.1,C50H58FN11O6S,246,1730,5.7,69,5,14,19,"InChI=1S/C50H58FN11O6S/c1-29-35(38-25-55-49(62-27-57-60-46(38)62)54-24-37-36-19-21-68-41(36)17-16-39(37)51)15-13-33(58-29)14-18-42(64)52-20-7-6-8-43(65)59-45(50(3,4)5)48(67)61-26-34(63)22-40(61)47(66)53-23-31-9-11-32(12-10-31)44-30(2)56-28-69-44/h9-13,15-17,25,27-28,34,40,45,63H,6-8,14,18-24,26H2,1-5H3,(H,52,64)(H,53,66)(H,54,55)(H,59,65)/t34-,40+,45-/m1/s1",CC1=C(C=CC(=N1)CCC(=O)NCCCCC(=O)N[C@H](C(=O)N2C[C@@H](C[C@H]2C(=O)NCC3=CC=C(C=C3)C4=C(N=CS4)C)O)C(C)(C)C)C5=CN=C(N6C5=NN=C6)NCC7=C(C=CC8=C7CCO8)F,CQSOTYMFUWTIIR-HUSBZTEESA-N,"(2S,4R)-1-[(2S)-2-[5-[3-[5-[5-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methylamino]-[1,2,4]triazolo[4,3-c]pyrimidin-8-yl]-6-methylpyridin-2-yl]propanoylamino]pentanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,NULL,0,NULL,20200220,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
145925673,PROTAC CDK2/9 Degrader-1,PROTAC CDK2/9 Degrader-1|CHEMBL4642944|BDBM50537765|HY-130709|CS-0112136,815.8,C40H41N13O7,260,1620,1.3,60,7,13,14,"InChI=1S/C40H41N13O7/c54-30(42-15-14-41-27-3-1-2-25-33(27)40(60)53(39(25)59)29-8-9-31(55)49-37(29)57)10-11-32(56)52-18-16-51(17-19-52)21-23-4-6-24(7-5-23)47-38(58)34-28(20-46-50-34)48-36-26-12-13-43-35(26)44-22-45-36/h1-7,12-13,20,22,29,41H,8-11,14-19,21H2,(H,42,54)(H,46,50)(H,47,58)(H,49,55,57)(H2,43,44,45,48)",C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCNC(=O)CCC(=O)N4CCN(CC4)CC5=CC=C(C=C5)NC(=O)C6=C(C=NN6)NC7=NC=NC8=C7C=CN8,BRYMZSSAIDEFEM-UHFFFAOYSA-N,"N-[4-[[4-[4-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethylamino]-4-oxobutanoyl]piperazin-1-yl]methyl]phenyl]-4-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1H-pyrazole-5-carboxamide",NULL,Classification,1,NULL,20200220,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE|MolPort,Chemical Vendors|Curation Efforts|Research and Development,NULL
146673056,PROTAC Bcl-xL degrader-1,PROTAC Bcl-xL degrader-1|HY-131188|CS-0130227,1514.3,C76H96ClF3N10O11S3,291,3160,11.5,104,5,20,26,"InChI=1S/C76H96ClF3N10O11S3/c1-50(81-6)70(92)84-65-31-43-101-68-47-75(4,5)69(90(68)73(65)95)72(94)83-63-15-10-12-53-44-58(25-27-62(53)63)100-42-11-16-67(91)89-40-34-86(35-41-89)33-30-56(49-102-59-13-8-7-9-14-59)82-64-28-26-60(45-66(64)103(96,97)76(78,79)80)104(98,99)85-71(93)52-19-23-57(24-20-52)88-38-36-87(37-39-88)48-54-46-74(2,3)32-29-61(54)51-17-21-55(77)22-18-51/h7-9,13-14,17-28,44-45,50,56,63,65,68-69,81-82H,10-12,15-16,29-43,46-49H2,1-6H3,(H,83,94)(H,84,92)(H,85,93)/t50-,56+,63+,65-,68-,69+/m0/s1",C[C@@H](C(=O)N[C@H]1CCO[C@H]2CC([C@H](N2C1=O)C(=O)N[C@@H]3CCCC4=C3C=CC(=C4)OCCCC(=O)N5CCN(CC5)CC[C@H](CSC6=CC=CC=C6)NC7=C(C=C(C=C7)S(=O)(=O)NC(=O)C8=CC=C(C=C8)N9CCN(CC9)CC1=C(CCC(C1)(C)C)C1=CC=C(C=C1)Cl)S(=O)(=O)C(F)(F)F)(C)C)NC,HHMCHRRZMCHLLA-PYINPHMPSA-N,"(4S,7S,9aS)-N-[(1R)-6-[4-[4-[(3R)-3-[4-[[4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]benzoyl]sulfamoyl]-2-(trifluoromethylsulfonyl)anilino]-4-phenylsulfanylbutyl]piperazin-1-yl]-4-oxobutoxy]-1,2,3,4-tetrahydronaphthalen-1-yl]-8,8-dimethyl-4-[[(2S)-2-(methylamino)propanoyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]oxazepine-7-carboxamide",NULL,NULL,0,NULL,20200702,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
67446188,PROTAC BET-binding moiety 2,"PROTAC BET-binding moiety 2|(S)-4-(4-chlorophenyl)-6-methoxycarbonylmethyl-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-carboxylic acid|SCHEMBL2544021|AKOS037653348|HY-43723|CS-0091199|916493-82-8",444.9,C20H17ClN4O4S,135,717,3.3,30,1,8,5,"InChI=1S/C20H17ClN4O4S/c1-9-15-16(11-4-6-12(21)7-5-11)22-13(8-14(26)29-3)18-24-23-10(2)25(18)19(15)30-17(9)20(27)28/h4-7,13H,8H2,1-3H3,(H,27,28)/t13-/m0/s1",CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC)C4=CC=C(C=C4)Cl)C(=O)O,LZXZWZXAVDJSIL-ZDUSSCGKSA-N,"(9S)-7-(4-chlorophenyl)-9-(2-methoxy-2-oxoethyl)-5,13-dimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene-4-carboxylic acid",NULL,Literature|Patents,2,NULL,20121130,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|Chem-Space.com Database|Google Patents|IBM|MedChemexpress MCE|MolPort|Nature Chemical Biology|NextMove Software|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,NULL
124190914,PROTAC BET Degrader-10,PROTAC BET Degrader-10|SCHEMBL18380105|HY-112718|CS-0062872,783.3,C39H39ClN8O6S,213,1540,3.3,55,3,10,12,"InChI=1S/C39H39ClN8O6S/c1-20-21(2)55-39-32(20)34(23-11-13-25(40)14-12-23)43-27(35-46-45-22(3)47(35)39)18-31(51)41-17-6-4-5-10-29(49)42-19-24-8-7-9-26-33(24)38(54)48(37(26)53)28-15-16-30(50)44-36(28)52/h7-9,11-14,27-28H,4-6,10,15-19H2,1-3H3,(H,41,51)(H,42,49)(H,44,50,52)/t27-,28?/m0/s1",CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCCCCCC(=O)NCC4=C5C(=CC=C4)C(=O)N(C5=O)C6CCC(=O)NC6=O)C7=CC=C(C=C7)Cl)C,KVKRYCAWRGWYNN-MBMZGMDYSA-N,"6-[[2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetyl]amino]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]methyl]hexanamide",NULL,Patents,1,NULL,20170218,AbaChemScene|BenchChem|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
132260060,PROTAC BRD9-binding moiety 1,PROTAC BRD9-binding moiety 1|SCHEMBL19747295|AKOS037653347|HY-107445|CS-0028501|O=S1(CCC(CC1)NC(=N)C1=CC=2C(N(C=C(C=2S1)C1=CC(=C(OCC(=O)O)C=C1)OC)C)=O)=O,519.6,C23H25N3O7S2,185,980,1.2,35,2,9,7,"InChI=1S/C23H25N3O7S2/c1-26-11-16(13-3-4-17(18(9-13)32-2)33-12-20(27)28)21-15(23(26)29)10-19(34-21)22(24)25-14-5-7-35(30,31)8-6-14/h3-4,9-11,14H,5-8,12H2,1-2H3,(H2,24,25)(H,27,28)",CN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=C(C=C4)OCC(=O)O)OC,OLJITCURTVADQX-UHFFFAOYSA-N,"2-[4-[2-[N'-(1,1-dioxothian-4-yl)carbamimidoyl]-5-methyl-4-oxothieno[3,2-c]pyridin-7-yl]-2-methoxyphenoxy]acetic acid",NULL,Patents,1,NULL,20180129,AbaChemScene|AKos Consulting & Solutions|Chem-Space.com Database|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
134160242,Homo-PROTAC pVHL30 degrader 1,"Homo-PROTAC pVHL30 degrader 1|CM 11|2244684-49-7|N1,N20-bis((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)-3,6,9,12,15,18-hexaoxaicosanediamide|CM11|SCHEMBL23431331|EX-A5064|AKOS034834077|HY-111593|CS-0087823",1179.5,C58H82N8O14S2,335,1870,3.6,82,6,18,33,"InChI=1S/C58H82N8O14S2/c1-37-49(81-35-61-37)41-13-9-39(10-14-41)29-59-53(71)45-27-43(67)31-65(45)55(73)51(57(3,4)5)63-47(69)33-79-25-23-77-21-19-75-17-18-76-20-22-78-24-26-80-34-48(70)64-52(58(6,7)8)56(74)66-32-44(68)28-46(66)54(72)60-30-40-11-15-42(16-12-40)50-38(2)62-36-82-50/h9-16,35-36,43-46,51-52,67-68H,17-34H2,1-8H3,(H,59,71)(H,60,72)(H,63,69)(H,64,70)/t43-,44-,45+,46+,51-,52-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)NCC5=CC=C(C=C5)C6=C(N=CS6)C)O)C(C)(C)C)O,WGJCHHJGGFCCRS-DEYDLUNASA-N,"(2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[2-[2-[2-[2-[2-[2-[[(2S)-1-[(2S,4R)-4-hydroxy-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,Literature|Patents,2,NULL,20180620,AbaChemScene|AbMole Bioscience|AKos Consulting & Solutions|BenchChem|BLD Pharm|Chem-Space.com Database|ChemShuttle|Excenen Pharmatech|Google Patents|MedChemexpress MCE|MolPort|SureChEMBL|TargetMol (Target Molecule Corp.)|Tocris Bioscience,Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,NULL
141507298,PROTAC BRD4 Degrader-2,PROTAC BRD4 Degrader-2|CHEMBL4633500|BDBM50539093|HY-133136|CS-0112161,757.8,C40H39N9O7,185,1480,1.7,56,2,10,11,"InChI=1S/C40H39N9O7/c1-23-36(24(2)56-44-23)26-12-13-32-29(18-26)37(25-8-5-4-6-9-25)49(40(54)46(32)3)20-27-19-47(45-43-27)16-17-55-22-35(51)41-31-11-7-10-28-30(31)21-48(39(28)53)33-14-15-34(50)42-38(33)52/h4-13,18-19,33,37H,14-17,20-22H2,1-3H3,(H,41,51)(H,42,50,52)",CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=O)N(C3C4=CC=CC=C4)CC5=CN(N=N5)CCOCC(=O)NC6=CC=CC7=C6CN(C7=O)C8CCC(=O)NC8=O)C,LSXNGBATZZFCNR-UHFFFAOYSA-N,"2-[2-[4-[[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-methyl-2-oxo-4-phenyl-4H-quinazolin-3-yl]methyl]triazol-1-yl]ethoxy]-N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]acetamide",NULL,Classification|Patents,2,NULL,20191206,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
145712396,PROTAC BRD2/BRD4 degrader-1,PROTAC BRD2/BRD4 degrader-1|CHEMBL4633483|HY-130612|CS-0109474,766.8,C39H38N6O9S,209,1620,3.4,55,4,11,14,"InChI=1S/C39H38N6O9S/c1-44-28-14-13-26(43-55(52,53)31-11-4-3-10-30(31)54-2)24-20-22(21-25(34(24)28)37(44)49)12-16-32(46)41-19-6-5-18-40-27-9-7-8-23-35(27)39(51)45(38(23)50)29-15-17-33(47)42-36(29)48/h3-4,7-11,13-14,20-21,29,40,43H,5-6,12,15-19H2,1-2H3,(H,41,46)(H,42,47,48)",CN1C2=C3C(=CC(=CC3=C(C=C2)NS(=O)(=O)C4=CC=CC=C4OC)CCC(=O)NCCCCNC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)C1=O,DCPKSVYPNGBDSB-UHFFFAOYSA-N,"N-[4-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]butyl]-3-[6-[(2-methoxyphenyl)sulfonylamino]-1-methyl-2-oxobenzo[cd]indol-4-yl]propanamide",NULL,Classification|Patents,2,NULL,20191231,AbaChemScene|ChEMBL|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
146026178,PROTAC FKBP Degrader-3,PROTAC FKBP Degrader-3|HY-135345|CS-0111726,1295.5,C68H90N6O17S,299,2250,7.7,92,4,19,36,"InChI=1S/C68H90N6O17S/c1-11-51(48-35-57(84-8)61(86-10)58(36-48)85-9)65(79)73-27-13-12-17-52(73)67(81)91-54(24-20-44-21-25-55(82-6)56(33-44)83-7)47-15-14-16-50(34-47)90-41-59(76)69-26-28-87-29-30-88-31-32-89-40-60(77)72-63(68(3,4)5)66(80)74-39-49(75)37-53(74)64(78)70-38-45-18-22-46(23-19-45)62-43(2)71-42-92-62/h14-16,18-19,21-23,25,33-36,42,49,51-54,63,75H,11-13,17,20,24,26-32,37-41H2,1-10H3,(H,69,76)(H,70,78)(H,72,77)/t49-,51+,52+,53+,54?,63-/m1/s1",CC[C@@H](C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCC[C@H]2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCC(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)NCC6=CC=C(C=C6)C7=C(N=CS7)C)O)C(C)(C)C,CCQROXFLIRBPGZ-DCXOQVPBSA-N,"[3-(3,4-dimethoxyphenyl)-1-[3-[2-[2-[2-[2-[2-[[(2S)-1-[(2S,4R)-4-hydroxy-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethoxy]phenyl]propyl] (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carboxylate",NULL,NULL,NA,NULL,20200430,AbaChemScene|BenchChem|MedChemexpress MCE|MolPort,Chemical Vendors,NULL
54764406,PROTAC ERalpha Degrader-2,PROTAC ERalpha Degrader-2|CHEMBL2151739|AKOS037653374|HY-111846|CS-0093244,764,C42H61N5O8,194,1260,4.1,55,6,10,20,"InChI=1S/C42H61N5O8/c1-27(2)23-36(46-41(52)39(50)35(43)24-28-7-5-4-6-8-28)40(51)45-18-20-54-22-21-53-19-17-44-38(49)26-55-47-37-14-13-34-33-11-9-29-25-30(48)10-12-31(29)32(33)15-16-42(34,37)3/h4-8,10,12,25,27,32-36,39,48,50H,9,11,13-24,26,43H2,1-3H3,(H,44,49)(H,45,51)(H,46,52)/b47-37+/t32-,33-,34+,35-,36+,39+,42+/m1/s1",CC(C)C[C@@H](C(=O)NCCOCCOCCNC(=O)CO/N=C/1\\CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)O)C)NC(=O)[C@H]([C@@H](CC5=CC=CC=C5)N)O,MMDOSMHAAYKBET-UTCZBAMKSA-N,"(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-N-[2-[2-[2-[[2-[(E)-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetyl]amino]ethoxy]ethoxy]ethyl]-4-methylpentanamide",NULL,Biological Test Results|Classification,2,690790,20120116,AbaChemScene|AKos Consulting & Solutions|BenchChem|ChEMBL|MedChemexpress MCE|MolPort|Thomson Pharma,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
131988582,PROTAC BET-binding moiety 1,"PROTAC BET-binding moiety 1|SCHEMBL19438842|TQR1035|AKOS037653349|HY-107451|CS-0028510|2093387-77-8|4-((3-Cyclopropyl-1-ethyl-1H-pyrazol-5-yl)amino)-7-(3,5-dimethylisoxazol-4-yl)-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxylic acid|C1(CC1)C1=NN(C(=C1)NC1=NC(=NC=2NC3=CC(=C(C=C3C=21)OC)C=1C(=NOC=1C)C)C(=O)O)CC",487.5,C25H25N7O4,144,817,4.1,36,3,9,7,"InChI=1S/C25H25N7O4/c1-5-32-19(10-16(30-32)13-6-7-13)27-23-21-14-9-18(35-4)15(20-11(2)31-36-12(20)3)8-17(14)26-22(21)28-24(29-23)25(33)34/h8-10,13H,5-7H2,1-4H3,(H,33,34)(H2,26,27,28,29)",CCN1C(=CC(=N1)C2CC2)NC3=NC(=NC4=C3C5=CC(=C(C=C5N4)C6=C(ON=C6C)C)OC)C(=O)O,DSICVZUZCUHARI-UHFFFAOYSA-N,"4-[(5-cyclopropyl-2-ethylpyrazol-3-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxylic acid",NULL,Patents,1,NULL,20180129,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|Chem-Space.com Database|ChemShuttle|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
134817208,Btk protac 10,BTK PROTAC 10,977,C47H54F2N8O13,267,1750,2.8,70,4,18,26,"InChI=1S/C47H54F2N8O13/c48-30-8-12-37(34(49)27-30)70-32-9-6-29(7-10-32)41-40(43(51)59)42(50)57(54-41)31-3-2-15-55(28-31)47(63)69-26-25-68-24-23-67-22-21-66-20-19-65-18-17-64-16-14-52-35-5-1-4-33-39(35)46(62)56(45(33)61)36-11-13-38(58)53-44(36)60/h1,4-10,12,27,31,36,52H,2-3,11,13-26,28,50H2,(H2,51,59)(H,53,58,60)/t31-,36?/m0/s1",C1C[C@@H](CN(C1)C(=O)OCCOCCOCCOCCOCCOCCNC2=CC=CC3=C2C(=O)N(C3=O)C4CCC(=O)NC4=O)N5C(=C(C(=N5)C6=CC=C(C=C6)OC7=C(C=C(C=C7)F)F)C(=O)N)N,XXNGOJVDXDGATG-BRKUKBBPSA-N,"2-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl (3S)-3-[5-amino-4-carbamoyl-3-[4-(2,4-difluorophenoxy)phenyl]pyrazol-1-yl]piperidine-1-carboxylate",NULL,NULL,0,NULL,20181002,DC Chemicals,Chemical Vendors,NULL
137045944,SMARCA-BD ligand 1 for Protac,"SMARCA-BD ligand 1 for Protac|2-(6-azanyl-5-piperazin-4-ium-1-yl-pyridazin-3-yl)phenol|FX5|SMARCABD|2-(6-amino-5-(piperazin-|SCHEMBL18038799|US10308614, Example 7|BDBM394406|HY-44012|CS-0101049|NC1=C(C=C(N=N1)C1=C(C=CC=C1)O)N1CCNCC1",271.32,C14H17N5O,87.3,310,0.3,20,3,6,2,"InChI=1S/C14H17N5O/c15-14-12(19-7-5-16-6-8-19)9-11(17-18-14)10-3-1-2-4-13(10)20/h1-4,9,16,20H,5-8H2,(H2,15,18)",C1CN(CCN1)C2=CC(=NN=C2N)C3=CC=CC=C3O,SZKHGLTYXIDOFH-UHFFFAOYSA-N,2-(6-amino-5-piperazin-1-ylpyridazin-3-yl)phenol,NULL,Biomolecular Interactions and Pathways|Literature|Patents,3,NULL,20190125,A2B Chem|AA BLOCKS|AbaChemScene|BenchChem|BindingDB|Chem-Space.com Database|Google Patents|MedChemexpress MCE|MolPort|Nature Chemical Biology|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|TargetMol (Target Molecule Corp.)|Thieme Chemistry,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
137319718,PROTAC BET degrader-2,PROTAC BET degrader-2|2093388-33-9|CHEMBL4224983|AKOS037653369|HY-114228|CS-0080216,770.8,C41H42N10O6,202,1520,4.4,57,4,11,12,"InChI=1S/C41H42N10O6/c1-5-51-32(18-28(48-51)23-11-12-23)44-37-35-25-17-31(56-4)26(34-20(2)49-57-21(34)3)16-29(25)43-36(35)46-38(47-37)40(54)42-15-7-9-22-8-6-10-24-27(22)19-50(41(24)55)30-13-14-33(52)45-39(30)53/h6,8,10,16-18,23,30H,5,7,9,11-15,19H2,1-4H3,(H,42,54)(H,45,52,53)(H2,43,44,46,47)",CCN1C(=CC(=N1)C2CC2)NC3=NC(=NC4=C3C5=CC(=C(C=C5N4)C6=C(ON=C6C)C)OC)C(=O)NCCCC7=C8CN(C(=O)C8=CC=C7)C9CCC(=O)NC9=O,LKCUEUQTTCOYPW-UHFFFAOYSA-N,"4-[(5-cyclopropyl-2-ethylpyrazol-3-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[3-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]propyl]-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide",NULL,Biological Test Results|Classification|Biological Test Results: Active|Biological Test Results: Micromolar,4,1387719|1387720|1387747|1387748|1387749,20190128,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|BOC Sciences|Chem-Space.com Database|ChEMBL|CSNpharm|DC Chemicals|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,NULL
138693144,PROTAC ER Degrader-4,PROTAC ER Degrader-4|CHEMBL4476831|SCHEMBL21068257|BDBM50502988|HY-135309|CS-0111216|2361114-15-8,1005.2,C53H67F3N6O8S,196,1720,7.3,71,4,14,22,"InChI=1S/C53H67F3N6O8S/c1-31-23-39-38-11-9-10-12-42(38)59-46(39)47(62(31)29-53(7,8)56)45-40(54)25-37(26-41(45)55)70-22-21-68-18-17-67-19-20-69-28-44(64)60-49(52(4,5)6)51(66)61-27-36(63)24-43(61)50(65)58-32(2)34-13-15-35(16-14-34)48-33(3)57-30-71-48/h9-16,25-26,30-32,36,43,47,49,59,63H,17-24,27-29H2,1-8H3,(H,58,65)(H,60,64)/t31-,32+,36-,43+,47-,49-/m1/s1",C[C@@H]1CC2=C([C@H](N1CC(C)(C)F)C3=C(C=C(C=C3F)OCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@H](C)C5=CC=C(C=C5)C6=C(N=CS6)C)O)C(C)(C)C)F)NC7=CC=CC=C27,WNWBHGDKGOSOKU-QIINAUKOSA-N,"(2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide",NULL,Classification|Patents,2,NULL,20190720,AbaChemScene|BindingDB|BLD Pharm|ChEMBL|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
138694806,PROTAC IRAK4 ligand-1,PROTAC IRAK4 ligand-1|SCHEMBL21070011|HY-129967|CS-0108938,612.6,C29H27F3N6O6,153,1050,4.3,44,2,12,10,"InChI=1S/C29H27F3N6O6/c1-28(2,3)44-27(42)37(13-16-4-5-16)22-12-18(10-11-33-22)25-35-21(15-43-25)24(39)34-20-14-38(36-23(20)29(30,31)32)19-8-6-17(7-9-19)26(40)41/h6-12,14-16H,4-5,13H2,1-3H3,(H,34,39)(H,40,41)",CC(C)(C)OC(=O)N(CC1CC1)C2=NC=CC(=C2)C3=NC(=CO3)C(=O)NC4=CN(N=C4C(F)(F)F)C5=CC=C(C=C5)C(=O)O,OGQQZVUJIJYUID-UHFFFAOYSA-N,"4-[4-[[2-[2-[cyclopropylmethyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]pyridin-4-yl]-1,3-oxazole-4-carbonyl]amino]-3-(trifluoromethyl)pyrazol-1-yl]benzoic acid",NULL,Patents,1,NULL,20190720,AbaChemScene|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
138911384,PROTAC MDM2 Degrader-2,PROTAC MDM2 Degrader-2|HY-128841|CS-0100639,1391.2,C70H76Cl4N10O12,226,2460,8.9,96,2,14,25,"InChI=1S/C70H76Cl4N10O12/c1-43(2)95-57-37-53(91-5)23-25-55(57)67-77-63(45-7-15-49(71)16-8-45)65(47-11-19-51(73)20-12-47)83(67)69(89)81-31-29-79(61(87)41-81)39-59(85)75-27-33-93-35-36-94-34-28-76-60(86)40-80-30-32-82(42-62(80)88)70(90)84-66(48-13-21-52(74)22-14-48)64(46-9-17-50(72)18-10-46)78-68(84)56-26-24-54(92-6)38-58(56)96-44(3)4/h7-26,37-38,43-44,63-66H,27-36,39-42H2,1-6H3,(H,75,85)(H,76,86)/t63-,64-,65+,66+/m1/s1",CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCN(C(=O)C3)CC(=O)NCCOCCOCCNC(=O)CN4CCN(CC4=O)C(=O)N5[C@H]([C@H](N=C5C6=C(C=C(C=C6)OC)OC(C)C)C7=CC=C(C=C7)Cl)C8=CC=C(C=C8)Cl)C9=CC=C(C=C9)Cl)C1=CC=C(C=C1)Cl,WZLSSHVSGKCEKQ-AKOOKZATSA-N,"2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]-N-[2-[2-[2-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]ethoxy]ethoxy]ethyl]acetamide",NULL,NULL,NA,NULL,20190902,AbaChemScene|BenchChem|MedChemexpress MCE|MolPort,Chemical Vendors,NULL
139035048,PROTAC Mcl1 degrader-1,"PROTAC Mcl1 degrader-1|CHEMBL4460727|2163793-38-0|Mcl-1 Degrader C3|BDBM50505351|HY-125877|CS-0102617|N1-(2-(6-((4-Bromophenyl)thio)-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)ethyl)-N6-(6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexyl)adipamide",909.8,C45H45BrN6O8S,217,1660,6,61,4,10,19,"InChI=1S/C45H45BrN6O8S/c46-27-15-17-28(18-16-27)61-35-21-19-32-39-29(35)9-7-10-30(39)42(57)51(43(32)58)26-25-49-37(54)14-4-3-13-36(53)48-24-6-2-1-5-23-47-33-12-8-11-31-40(33)45(60)52(44(31)59)34-20-22-38(55)50-41(34)56/h7-12,15-19,21,34,47H,1-6,13-14,20,22-26H2,(H,48,53)(H,49,54)(H,50,55,56)",C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCCCCCNC(=O)CCCCC(=O)NCCN4C(=O)C5=C6C(=C(C=C5)SC7=CC=C(C=C7)Br)C=CC=C6C4=O,BORXNUWYWZOREQ-UHFFFAOYSA-N,"N'-[2-[6-(4-bromophenyl)sulfanyl-1,3-dioxobenzo[de]isoquinolin-2-yl]ethyl]-N-[6-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]hexyl]hexanediamide",NULL,Classification,1,NULL,20190930,A2B Chem|AA BLOCKS|AbaChemScene|BindingDB|BLD Pharm|Chem-Space.com Database|ChEMBL|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.)|THE BioTek,Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,NULL
141488040,PROTAC BRD4-binding moiety 1,PROTAC BRD4-binding moiety 1|HY-107442|CS-0028498,371.4,C23H21N3O2,49.6,623,3.5,28,0,3,3,"InChI=1S/C23H21N3O2/c1-5-13-26-22(17-9-7-6-8-10-17)19-14-18(21-15(2)24-28-16(21)3)11-12-20(19)25(4)23(26)27/h1,6-12,14,22H,13H2,2-4H3",CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=O)N(C3C4=CC=CC=C4)CC#C)C,ZKJVDZJHVLJOKO-UHFFFAOYSA-N,"6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-methyl-4-phenyl-3-prop-2-ynyl-4H-quinazolin-2-one",NULL,Names and Identifiers|Patents,2,NULL,20191206,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
146673078,PROTAC BRD4 Degrader-5,"PROTAC BRD4 Degrader-5|EX-A3958|HY-133737|CS-0130208|(2S,4R)-1-((S)-2-(tert-butyl)-17-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecan-1-oyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide|2409538-70-9",1016.7,C50H62ClN9O8S2,268,1790,5.4,70,4,14,21,"InChI=1S/C50H62ClN9O8S2/c1-28-31(4)70-49-42(28)43(34-13-15-36(51)16-14-34)55-38(46-58-57-32(5)60(46)49)24-40(62)52-17-18-66-19-20-67-21-22-68-26-41(63)56-45(50(6,7)8)48(65)59-25-37(61)23-39(59)47(64)54-29(2)33-9-11-35(12-10-33)44-30(3)53-27-69-44/h9-16,27,29,37-39,45,61H,17-26H2,1-8H3,(H,52,62)(H,54,64)(H,56,63)/t29-,37+,38-,39-,45+/m0/s1",CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@H](C)C5=CC=C(C=C5)C6=C(N=CS6)C)O)C(C)(C)C)C7=CC=C(C=C7)Cl)C,SLPWRCRRHVRNRM-BEGQQDOQSA-N,"(2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[[2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetyl]amino]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide",NULL,NULL,0,NULL,20200702,AbaChemScene|ChemShuttle|Excenen Pharmatech|MedChemexpress MCE,Chemical Vendors,NULL
54764407,PROTAC AR Degrader-4,"PROTAC AR Degrader-4|CHEMBL2151741|AKOS037653397|HY-111848|CS-0093246|17beta-[[8-[[N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucyl]amino]-3,6-dioxaoctane-1-yloxy]acetoxy]-5alpha-androstane-3-one",770,C43H67N3O9,176,1280,4.8,55,4,10,21,"InChI=1S/C43H67N3O9/c1-28(2)24-36(46-41(51)39(49)35(44)25-29-8-6-5-7-9-29)40(50)45-18-19-52-20-21-53-22-23-54-27-38(48)55-37-13-12-33-32-11-10-30-26-31(47)14-16-42(30,3)34(32)15-17-43(33,37)4/h5-9,28,30,32-37,39,49H,10-27,44H2,1-4H3,(H,45,50)(H,46,51)/t30-,32-,33-,34-,35+,36-,37-,39-,42-,43-/m0/s1",CC(C)C[C@@H](C(=O)NCCOCCOCCOCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CCC(=O)C4)C)C)NC(=O)[C@H]([C@@H](CC5=CC=CC=C5)N)O,YNDJPWSVYYRNTJ-MEXKHVBFSA-N,"[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] 2-[2-[2-[2-[[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]amino]ethoxy]ethoxy]ethoxy]acetate",NULL,Biological Test Results|Classification,2,690789,20120116,AbaChemScene|AKos Consulting & Solutions|ChEMBL|Japan Chemical Substance Dictionary (Nikkaji)|MedChemexpress MCE|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
126696039,PROTAC RIPK degrader-6,PROTAC RIPK degrader-6|SCHEMBL18640013|HY-111870|CS-0093291|2089205-64-9|S1C=NC2=C1C=CC(=C2)NC1=CC=NC2=CC(=C(C=C12)S(=O)(=O)C(C)(C)C)OCCOCCOCCOCCOCC(=O)NC1=C2CN(C(C2=CC=C1)=O)C1C(NC(CC1)=O)=O,889,C43H48N6O11S2,250,1650,3,62,3,15,21,"InChI=1S/C43H48N6O11S2/c1-43(2,3)62(54,55)38-22-29-32(46-27-7-9-37-34(21-27)45-26-61-37)11-12-44-33(29)23-36(38)60-20-19-58-16-15-56-13-14-57-17-18-59-25-40(51)47-31-6-4-5-28-30(31)24-49(42(28)53)35-8-10-39(50)48-41(35)52/h4-7,9,11-12,21-23,26,35H,8,10,13-20,24-25H2,1-3H3,(H,44,46)(H,47,51)(H,48,50,52)",CC(C)(C)S(=O)(=O)C1=CC2=C(C=CN=C2C=C1OCCOCCOCCOCCOCC(=O)NC3=CC=CC4=C3CN(C4=O)C5CCC(=O)NC5=O)NC6=CC7=C(C=C6)SC=N7,BRZGXSNAXRPPFI-UHFFFAOYSA-N,"2-[2-[2-[2-[2-[4-(1,3-benzothiazol-5-ylamino)-6-tert-butylsulfonylquinolin-7-yl]oxyethoxy]ethoxy]ethoxy]ethoxy]-N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]acetamide",NULL,Patents,1,NULL,20170422,A2B Chem|AA BLOCKS|AbaChemScene|BenchChem|Google Patents|MedChemexpress MCE|MolPort|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,NULL
134817207,Btk protac 9,BTK PROTAC 9,946.9,C46H52F2N8O12,258,1720,2.4,68,4,17,24,"InChI=1S/C46H52F2N8O12/c47-29-8-12-36(33(48)25-29)68-31-9-6-28(7-10-31)41-40(43(50)59)42(49)56(53-41)30-3-2-15-54(26-30)38(58)27-67-24-23-66-22-21-65-20-19-64-18-17-63-16-14-51-34-5-1-4-32-39(34)46(62)55(45(32)61)35-11-13-37(57)52-44(35)60/h1,4-10,12,25,30,35,51H,2-3,11,13-24,26-27,49H2,(H2,50,59)(H,52,57,60)/t30-,35?/m0/s1",C1C[C@@H](CN(C1)C(=O)COCCOCCOCCOCCOCCNC2=CC=CC3=C2C(=O)N(C3=O)C4CCC(=O)NC4=O)N5C(=C(C(=N5)C6=CC=C(C=C6)OC7=C(C=C(C=C7)F)F)C(=O)N)N,PDQGUWCWGITGBA-KIYCQYGCSA-N,"5-amino-3-[4-(2,4-difluorophenoxy)phenyl]-1-[(3S)-1-[2-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetyl]piperidin-3-yl]pyrazole-4-carboxamide",NULL,NULL,0,NULL,20181002,DC Chemicals,Chemical Vendors,NULL
137319719,PROTAC BET degrader-3,PROTAC BET degrader-3|AKOS037653365|HY-114229|CS-0080219,1045.2,C53H64N12O9S,294,1930,5.7,75,6,16,22,"InChI=1S/C53H64N12O9S/c1-9-65-41(23-37(62-65)32-14-15-32)58-48-44-35-22-40(71-8)36(43-28(2)63-74-30(43)4)21-38(35)57-47(44)60-49(61-48)51(69)54-16-17-72-18-19-73-26-42(67)59-46(53(5,6)7)52(70)64-25-34(66)20-39(64)50(68)55-24-31-10-12-33(13-11-31)45-29(3)56-27-75-45/h10-13,21-23,27,32,34,39,46,66H,9,14-20,24-26H2,1-8H3,(H,54,69)(H,55,68)(H,59,67)(H2,57,58,60,61)/t34-,39+,46-/m1/s1",CCN1C(=CC(=N1)C2CC2)NC3=NC(=NC4=C3C5=CC(=C(C=C5N4)C6=C(ON=C6C)C)OC)C(=O)NCCOCCOCC(=O)N[C@H](C(=O)N7C[C@@H](C[C@H]7C(=O)NCC8=CC=C(C=C8)C9=C(N=CS9)C)O)C(C)(C)C,FELAEQXENPWHOL-UNRSLVJTSA-N,"4-[(5-cyclopropyl-2-ethylpyrazol-3-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[2-[2-[2-[[(2S)-1-[(2S,4R)-4-hydroxy-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethoxy]ethoxy]ethyl]-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide",NULL,NULL,NA,NULL,20190128,AbaChemScene|AKos Consulting & Solutions|Chem-Space.com Database|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.),Chemical Vendors|Legacy Depositors,NULL
137628615,cis-PROTAC 2,cis-PROTAC 2,920.1,C49H58FN9O6S,228,1630,5.3,66,5,14,16,"InChI=1S/C49H58FN9O6S/c1-30-42(66-29-53-30)33-13-14-34(26-52-45(62)39-24-35(60)28-59(39)46(63)43(48(2,3)4)54-47(64)49(50)16-17-49)41(23-33)65-22-15-31-9-11-32(12-10-31)27-57-18-20-58(21-19-57)38-25-37(55-56-44(38)51)36-7-5-6-8-40(36)61/h5-14,23,25,29,35,39,43,60-61H,15-22,24,26-28H2,1-4H3,(H2,51,56)(H,52,62)(H,54,64)/t35-,39-,43+/m0/s1",CC1=C(SC=N1)C2=CC(=C(C=C2)CNC(=O)[C@@H]3C[C@@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)C4(CC4)F)O)OCCC5=CC=C(C=C5)CN6CCN(CC6)C7=CC(=NN=C7N)C8=CC=CC=C8O,UTZVLJZPTDCKCT-ZRRKANIKSA-N,"(2S,4S)-N-[[2-[2-[4-[[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]methyl]phenyl]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxypyrrolidine-2-carboxamide",NULL,Literature,1,NULL,20190408,Nature Chemical Biology,Journal Publishers,NULL
138911383,PROTAC MDM2 Degrader-1,PROTAC MDM2 Degrader-1|HY-128840|CS-0100638,1463.3,C74H84Cl4N10O13,235,2550,9.5,101,2,15,30,"InChI=1S/C74H84Cl4N10O13/c1-47(2)100-61-41-57(95-5)25-27-59(61)71-81-67(49-9-17-53(75)18-10-49)69(51-13-21-55(77)22-14-51)87(71)73(93)85-33-31-83(65(91)45-85)43-63(89)79-29-7-35-97-37-39-99-40-38-98-36-8-30-80-64(90)44-84-32-34-86(46-66(84)92)74(94)88-70(52-15-23-56(78)24-16-52)68(50-11-19-54(76)20-12-50)82-72(88)60-28-26-58(96-6)42-62(60)101-48(3)4/h9-28,41-42,47-48,67-70H,7-8,29-40,43-46H2,1-6H3,(H,79,89)(H,80,90)/t67-,68-,69+,70+/m1/s1",CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCN(C(=O)C3)CC(=O)NCCCOCCOCCOCCCNC(=O)CN4CCN(CC4=O)C(=O)N5[C@H]([C@H](N=C5C6=C(C=C(C=C6)OC)OC(C)C)C7=CC=C(C=C7)Cl)C8=CC=C(C=C8)Cl)C9=CC=C(C=C9)Cl)C1=CC=C(C=C1)Cl,AQFZQNOXRSZHMG-PQMVWXROSA-N,"2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]-N-[3-[2-[2-[3-[[2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetyl]amino]propoxy]ethoxy]ethoxy]propyl]acetamide",NULL,NULL,NA,NULL,20190902,AbaChemScene|BenchChem|MedChemexpress MCE|MolPort,Chemical Vendors,NULL
139035047,PROTAC Bcl2 degrader-1,"PROTAC Bcl2 degrader-1|CHEMBL4565306|2378801-85-3|N1-(2-(6-((4-Bromophenyl)thio)-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)ethyl)-N6-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethyl)adipamide|BCL2 Degrader C5|BDBM50505358|HY-125876|CS-0102616",941.8,C45H45BrN6O10S,235,1700,4.3,63,4,12,21,"InChI=1S/C45H45BrN6O10S/c46-27-11-13-28(14-12-27)63-35-17-15-32-39-29(35)5-3-6-30(39)42(57)51(43(32)58)22-19-48-36(53)9-1-2-10-37(54)49-21-24-62-26-25-61-23-20-47-33-8-4-7-31-40(33)45(60)52(44(31)59)34-16-18-38(55)50-41(34)56/h3-8,11-15,17,34,47H,1-2,9-10,16,18-26H2,(H,48,53)(H,49,54)(H,50,55,56)",C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCOCCOCCNC(=O)CCCCC(=O)NCCN4C(=O)C5=C6C(=C(C=C5)SC7=CC=C(C=C7)Br)C=CC=C6C4=O,IUSLKFLLLNNOGR-UHFFFAOYSA-N,"N-[2-[6-(4-bromophenyl)sulfanyl-1,3-dioxobenzo[de]isoquinolin-2-yl]ethyl]-N'-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethyl]hexanediamide",NULL,Classification,1,NULL,20190930,A2B Chem|AA BLOCKS|AbaChemScene|BindingDB|BLD Pharm|Chem-Space.com Database|ChEMBL|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.)|THE BioTek,Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,NULL
141488039,PROTAC BRD4 Degrader-1,"PROTAC BRD4 Degrader-1|CHEMBL4640303|BDBM50539098|HY-133131|CS-0112150|2133360-00-4|Acetamide, 2-[2-[4-[[6-(3,5-dimethyl-4-isoxazolyl)-1,4-dihydro-1-methyl-2-oxo-4-phenyl-3(2H)-quinazolinyl]methyl]-1H-1,2,3-triazol-1-yl]ethoxy]-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-",771.8,C40H37N9O8,202,1560,2.2,57,2,11,11,"InChI=1S/C40H37N9O8/c1-22-34(23(2)57-44-22)25-12-13-30-28(18-25)36(24-8-5-4-6-9-24)48(40(55)46(30)3)20-26-19-47(45-43-26)16-17-56-21-33(51)41-29-11-7-10-27-35(29)39(54)49(38(27)53)31-14-15-32(50)42-37(31)52/h4-13,18-19,31,36H,14-17,20-21H2,1-3H3,(H,41,51)(H,42,50,52)",CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=O)N(C3C4=CC=CC=C4)CC5=CN(N=N5)CCOCC(=O)NC6=CC=CC7=C6C(=O)N(C7=O)C8CCC(=O)NC8=O)C,FXNACIMQXOPNJG-UHFFFAOYSA-N,"2-[2-[4-[[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-methyl-2-oxo-4-phenyl-4H-quinazolin-3-yl]methyl]triazol-1-yl]ethoxy]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]acetamide",NULL,Classification|Names and Identifiers|Patents,3,NULL,20191206,A2B Chem|AA BLOCKS|AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
54764325,PROTAC RAR Degrader-1,PROTAC RAR Degrader-1|CHEMBL2151737|1351169-27-1|AKOS037653375|HY-111844|CS-0093242,917.1,C51H72N4O11,225,1480,4.4,66,6,12,30,"InChI=1S/C51H72N4O11/c1-34(2)27-42(55-48(60)46(58)41(52)28-35-13-10-9-11-14-35)47(59)54-20-22-63-23-24-64-25-26-65-33-45(57)53-19-12-21-66-44-29-36(15-17-40(44)49(61)62)16-18-43(56)37-30-38(50(3,4)5)32-39(31-37)51(6,7)8/h9-11,13-18,29-32,34,41-42,46,58H,12,19-28,33,52H2,1-8H3,(H,53,57)(H,54,59)(H,55,60)(H,61,62)/b18-16+/t41-,42+,46+/m1/s1",CC(C)C[C@@H](C(=O)NCCOCCOCCOCC(=O)NCCCOC1=C(C=CC(=C1)/C=C/C(=O)C2=CC(=CC(=C2)C(C)(C)C)C(C)(C)C)C(=O)O)NC(=O)[C@H]([C@@H](CC3=CC=CC=C3)N)O,ZAOSGDCLGNWLSI-ACALULJJSA-N,"2-[3-[[2-[2-[2-[2-[[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoyl]amino]ethoxy]ethoxy]ethoxy]acetyl]amino]propoxy]-4-[(E)-3-(3,5-ditert-butylphenyl)-3-oxoprop-1-enyl]benzoic acid",NULL,Biological Test Results|Classification,2,690792|690794|690795|690796,20120116,AbaChemScene|AKos Consulting & Solutions|BLD Pharm|Chem-Space.com Database|ChEMBL|MedChemexpress MCE|Thomson Pharma,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
124108661,TBK1 PROTAC 3i,"CHEMBL4227907|TBK1 PROTAC 3i|SCHEMBL18282349|GTPL11661|BDBM50459898|compound 3i [PMID: 28692295]|(2S,4R)-1-[(2S)-2-[[2-[3-[4-[3-[4-[[5-bromo-4-[3-[cyclobutanecarbonyl(methyl)amino]propylamino]pyrimidin-2-yl]amino]phenoxy]propoxy]butoxy]propoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",1093.2,C53H74BrN9O9S,247,1650,7,73,5,15,31,"InChI=1S/C53H74BrN9O9S/c1-36-46(73-35-58-36)38-16-14-37(15-17-38)31-56-49(66)44-30-41(64)33-63(44)51(68)47(53(2,3)4)60-45(65)34-71-28-10-26-69-24-6-7-25-70-27-11-29-72-42-20-18-40(19-21-42)59-52-57-32-43(54)48(61-52)55-22-9-23-62(5)50(67)39-12-8-13-39/h14-21,32,35,39,41,44,47,64H,6-13,22-31,33-34H2,1-5H3,(H,56,66)(H,60,65)(H2,55,57,59,61)/t41-,44+,47-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCCOCCCCOCCCOC4=CC=C(C=C4)NC5=NC=C(C(=N5)NCCCN(C)C(=O)C6CCC6)Br)O,QMGHHBHPDDAGGO-IIWOMYBWSA-N,"(2S,4R)-1-[(2S)-2-[[2-[3-[4-[3-[4-[[5-bromo-4-[3-[cyclobutanecarbonyl(methyl)amino]propylamino]pyrimidin-2-yl]amino]phenoxy]propoxy]butoxy]propoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,Biological Test Results|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,1388068|1388069|1388070|1388071|1388072|1388075|1388076|1388077|1388078|1388079|1388080|1388081|1388082|1388083|1388084|1388085|1388086|1388087|1388088|1388089|1388090|1388092,20170218,BenchChem|BindingDB|ChEMBL|IUPHAR/BPS Guide to PHARMACOLOGY|MolPort|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
132144837,PROTAC ERalpha Degrader-1,PROTAC ERalpha Degrader-1|SCHEMBL19616620|AKOS037653373|HY-112098|CS-0043343,1120.3,C66H69N7O10,212,2180,9.4,83,4,12,24,"InChI=1S/C66H69N7O10/c1-7-54(46-13-9-8-10-14-46)61(48-22-27-52(74)28-23-48)49-24-29-53(30-25-49)83-36-34-71(5)60(75)42-82-38-37-81-35-33-69-64(77)50-18-20-51(21-19-50)65(78)73-44(3)62(70-63(76)43(2)68-4)66(79)72(57-31-17-45(40-67)39-58(57)73)41-56-55-16-12-11-15-47(55)26-32-59(56)80-6/h8-32,39,43-44,62,68,74H,7,33-38,41-42H2,1-6H3,(H,69,77)(H,70,76)/b61-54-/t43-,44-,62-/m0/s1",CC/C(=C(\\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C(=O)COCCOCCNC(=O)C3=CC=C(C=C3)C(=O)N4[C@H]([C@@H](C(=O)N(C5=C4C=C(C=C5)C#N)CC6=C(C=CC7=CC=CC=C76)OC)NC(=O)[C@H](C)NC)C)/C8=CC=CC=C8,SNBOCOFSYPHJLP-XJQCFLMPSA-N,"4-[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-3-[[(2S)-2-(methylamino)propanoyl]amino]-2-oxo-3,4-dihydro-1,5-benzodiazepine-5-carbonyl]-N-[2-[2-[2-[2-[4-[(Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl-methylamino]-2-oxoethoxy]ethoxy]ethyl]benzamide",NULL,Patents,1,NULL,20180129,AbaChemScene|AKos Consulting & Solutions|BenchChem|Chem-Space.com Database|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
134691733,PROTAC BET Degrader-1,"PROTAC BET Degrader-1|2093386-22-0|CHEMBL4226900|SCHEMBL21082297|EX-A3888|AKOS037653372|HY-103633|CS-0028483|4-((3-cyclopropyl-1-ethyl-1H-pyrazol-5-yl)amino)-7-(3,5-dimethylisoxazol-4-yl)-N-(4-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)butyl)-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide",871.9,C44H45N11O9,258,1770,3.8,64,5,14,16,"InChI=1S/C44H45N11O9/c1-5-54-32(19-27(52-54)23-11-12-23)48-39-37-25-18-31(62-4)26(35-21(2)53-64-22(35)3)17-28(25)47-38(37)50-40(51-39)42(59)46-16-7-6-15-45-34(57)20-63-30-10-8-9-24-36(30)44(61)55(43(24)60)29-13-14-33(56)49-41(29)58/h8-10,17-19,23,29H,5-7,11-16,20H2,1-4H3,(H,45,57)(H,46,59)(H,49,56,58)(H2,47,48,50,51)",CCN1C(=CC(=N1)C2CC2)NC3=NC(=NC4=C3C5=CC(=C(C=C5N4)C6=C(ON=C6C)C)OC)C(=O)NCCCCNC(=O)COC7=CC=CC8=C7C(=O)N(C8=O)C9CCC(=O)NC9=O,TXLUZGFDBDQACL-UHFFFAOYSA-N,"4-[(5-cyclopropyl-2-ethylpyrazol-3-yl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide",NULL,Biological Test Results|Classification|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,5,1387719|1387720|1387750|1387751|1387779,20180731,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemShuttle|Excenen Pharmatech|Google Patents|MedChemexpress MCE|MolPort|SureChEMBL|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,NULL
138454773,PROTAC FAK degrader 1,PROTAC FAK degrader 1|CHEMBL4447794|SCHEMBL21634231|2301916-69-6|EX-A3967|BDBM50520571|HY-119932|CS-0078799,996.1,C47H56F3N9O8S2,254,1760,5.8,69,5,18,21,"InChI=1S/C47H56F3N9O8S2/c1-29-40(68-28-54-29)32-12-10-30(11-13-32)24-52-43(62)38-23-35(60)27-59(38)44(63)41(46(2,3)4)56-39(61)18-19-66-20-21-67-36-16-14-33(15-17-36)55-45-53-26-37(47(48,49)50)42(57-45)51-25-31-8-7-9-34(22-31)58(5)69(6,64)65/h7-17,22,26,28,35,38,41,60H,18-21,23-25,27H2,1-6H3,(H,52,62)(H,56,61)(H2,51,53,55,57)/t35-,38+,41-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCOCCOC4=CC=C(C=C4)NC5=NC=C(C(=N5)NCC6=CC(=CC=C6)N(C)S(=O)(=O)C)C(F)(F)F)O,MVULIYLBRNHLEE-LFHXYJAASA-N,"(2S,4R)-1-[(2S)-3,3-dimethyl-2-[3-[2-[4-[[4-[[3-[methyl(methylsulfonyl)amino]phenyl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenoxy]ethoxy]propanoylamino]butanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",NULL,Classification|Patents,2,NULL,20190712,AbaChemScene|BenchChem|BindingDB|Chem-Space.com Database|ChEMBL|Excenen Pharmatech|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
139579413,PROTAC K-Ras Degrader-1,"PROTAC K-Ras Degrader-1|SCHEMBL21459082|EX-A3964|HY-129523|CS-0106329|2-((2S)-1-acryloyl-4-(2-(((2S,4R)-4-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethoxy)-1-methylpyrrolidin-2-yl)methoxy)-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile|2378258-52-5",999.1,C53H62N10O10,221,1970,3.7,73,2,17,22,"InChI=1S/C53H62N10O10/c1-3-47(65)62-22-21-61(31-36(62)16-18-54)49-40-17-20-60(44-13-6-9-35-8-4-5-10-39(35)44)33-43(40)56-53(58-49)73-34-37-30-38(32-59(37)2)72-29-28-71-27-26-70-25-24-69-23-19-55-42-12-7-11-41-48(42)52(68)63(51(41)67)45-14-15-46(64)57-50(45)66/h3-13,36-38,45,55H,1,14-17,19-34H2,2H3,(H,57,64,66)/t36-,37-,38+,45?/m0/s1",CN1C[C@@H](C[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=CC=CC=C54)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C=C)OCCOCCOCCOCCNC7=CC=CC8=C7C(=O)N(C8=O)C9CCC(=O)NC9=O,KGFCORDWMRCVAC-VYIZRSQBSA-N,"2-[(2S)-4-[2-[[(2S,4R)-4-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-1-methylpyrrolidin-2-yl]methoxy]-7-naphthalen-1-yl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-prop-2-enoylpiperazin-2-yl]acetonitrile",NULL,Patents,1,NULL,20191102,AbaChemScene|BenchChem|Chem-Space.com Database|ChemShuttle|Excenen Pharmatech|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.),Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
139600325,Halo PROTAC 1,Halo PROTAC 1|SCHEMBL21977324|HY-129652|CS-0107237|2241668-45-9,774.8,C33H49Cl2N7O8S,215,1050,1.9,51,4,11,28,"InChI=1S/C33H49Cl2N7O8S/c1-24(43)38-27(23-51-33-39-28-29(40-32(36)41-31(28)45)42(33)22-25-6-8-26(35)9-7-25)30(44)37-11-13-47-15-17-49-19-21-50-20-18-48-16-14-46-12-5-3-2-4-10-34/h6-9,27H,2-5,10-23H2,1H3,(H,37,44)(H,38,43)(H3,36,40,41,45)/t27-/m0/s1",CC(=O)N[C@@H](CSC1=NC2=C(N1CC3=CC=C(C=C3)Cl)N=C(NC2=O)N)C(=O)NCCOCCOCCOCCOCCOCCCCCCCl,PMKLWFIBYSGVNP-MHZLTWQESA-N,(2R)-2-acetamido-3-[[2-amino-9-[(4-chlorophenyl)methyl]-6-oxo-1H-purin-8-yl]sulfanyl]-N-[2-[2-[2-[2-[2-(6-chlorohexoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethyl]propanamide,NULL,Patents,1,NULL,20191129,AbaChemScene|BLD Pharm|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
145925653,CDK ligand for PROTAC (hydrochloride),CDK ligand for PROTAC (hydrochloride)|HY-126534A|CS-0112285,531,C25H29ClF2N8O,104,701,NULL,37,4,10,7,"InChI=1S/C25H28F2N8O.ClH/c1-15(2)35-20-10-17(9-18(26)24(20)32-22(35)14-36)23-19(27)12-30-25(33-23)31-21-4-3-16(11-29-21)13-34-7-5-28-6-8-34;/h3-4,9-12,15,28,36H,5-8,13-14H2,1-2H3,(H,29,30,31,33);1H",CC(C)N1C2=C(C(=CC(=C2)C3=NC(=NC=C3F)NC4=NC=C(C=C4)CN5CCNCC5)F)N=C1CO.Cl,WGFYSOPSZMTSSV-UHFFFAOYSA-N,[4-fluoro-6-[5-fluoro-2-[[5-(piperazin-1-ylmethyl)pyridin-2-yl]amino]pyrimidin-4-yl]-1-propan-2-ylbenzimidazol-2-yl]methanol;hydrochloride,NULL,NULL,NA,NULL,20200220,AbaChemScene|Chem-Space.com Database|MedChemexpress MCE|MolPort|TargetMol (Target Molecule Corp.),Chemical Vendors|Legacy Depositors,NULL
146026069,Fkbp12 protac RC32,FKBP12 PROTAC RC32|CHEMBL4591678|HY-130835|CS-0114364,1426.7,C75H107N7O20,338,2980,5.8,102,4,23,23,"InChI=1S/C75H107N7O20/c1-45-17-12-11-13-18-46(2)61(94-8)41-54-24-22-51(7)75(93,102-54)69(87)73(91)81-29-15-14-21-58(81)74(92)101-62(42-59(83)47(3)38-50(6)67(86)68(96-10)66(85)49(5)37-45)48(4)39-52-23-26-60(63(40-52)95-9)100-36-35-99-44-53-43-80(79-78-53)30-32-98-34-33-97-31-28-76-56-20-16-19-55-65(56)72(90)82(71(55)89)57-25-27-64(84)77-70(57)88/h11-13,16-20,38,43,45,47-49,51-52,54,57-58,60-63,67-68,76,86,93H,14-15,21-37,39-42,44H2,1-10H3,(H,77,84,88)/b13-11+,17-12+,46-18+,50-38+/t45-,47-,48-,49-,51-,52+,54+",C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCOCC5=CN(N=N5)CCOCCOCCNC6=CC=CC7=C6C(=O)N(C7=O)C8CCC(=O)NC8=O)C)/C)O)OC)C)C)/C)OC,XCSUEITWRRFFMN-SJQMKIJVSA-N,"(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-[2-[[1-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethyl]triazol-4-yl]methoxy]ethoxy]-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",NULL,Classification,1,NULL,20200430,AbaChemScene|ChEMBL|MedChemexpress MCE|MolPort,Chemical Vendors|Curation Efforts|Research and Development,NULL
146673077,PROTAC BRD4 Degrader-5-CO-PEG3-N3,PROTAC BRD4 Degrader-5-CO-PEG3-N3|HY-133736|CS-0130205,1231.9,C58H75ClN12O12S2,316,2220,6.4,85,3,20,34,"InChI=1S/C58H75ClN12O12S2/c1-35-38(4)85-57-50(35)51(41-13-15-43(59)16-14-41)65-45(54-68-67-39(5)71(54)57)30-47(72)61-17-19-77-21-23-79-25-27-81-32-48(73)66-53(58(6,7)8)56(76)70-31-44(83-49(74)33-82-28-26-80-24-22-78-20-18-63-69-60)29-46(70)55(75)64-36(2)40-9-11-42(12-10-40)52-37(3)62-34-84-52/h9-16,34,36,44-46,53H,17-33H2,1-8H3,(H,61,72)(H,64,75)(H,66,73)/t36-,44+,45-,46-,53+/m0/s1",CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@H](C)C5=CC=C(C=C5)C6=C(N=CS6)C)OC(=O)COCCOCCOCCN=[N+]=[N-])C(C)(C)C)C7=CC=C(C=C7)Cl)C,WMOYJXQCSDGERS-WVLZNWKQSA-N,"[(3R,5S)-1-[(2S)-2-[[2-[2-[2-[2-[[2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetyl]amino]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-5-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-3-yl] 2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]acetate",NULL,NULL,0,NULL,20200702,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
3706987,"((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate)","37860-51-8|((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate)|Bis-Tos-PEG4|Tetraethylene glycol ditosylate|Tetraethylene Glycol Di-p-tosylate|Tetraethylene glycol di(p-toluenesulfonate)|Tos-PEG5-Tos|PROTAC Linker 16|Tetraethylene Glycol Bis(p-toluenesulfonate)|MFCD00075239|2-[2-[2-[2-(4-methylphenyl)sulfonyloxyethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate|2-[2-(2-{2-[(4-methylbenzenesulfonyl)oxy]ethoxy}ethoxy)ethoxy]ethyl 4-methylbenzene-1-sulfonate|SCHEMBL1145153|te",502.6,C22H30O9S2,131,650,2.5,33,0,9,16,"InChI=1S/C22H30O9S2/c1-19-3-7-21(8-4-19)32(23,24)30-17-15-28-13-11-27-12-14-29-16-18-31-33(25,26)22-9-5-20(2)6-10-22/h3-10H,11-18H2,1-2H3",CC1=CC=C(C=C1)S(=O)(=O)OCCOCCOCCOCCOS(=O)(=O)C2=CC=C(C=C2)C,SLAONPBUWDUSSO-UHFFFAOYSA-N,2-[2-[2-[2-(4-methylphenyl)sulfonyloxyethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate,NULL,Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,5,NULL,20050910,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Accela ChemBio Inc.|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|Angene Chemical|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|Biosynth Carbosynth|BLD Pharm|BOC Sciences|BroadPharm|Chem-Space.com Database|Chembase.cn|ChemBridge|ChemDB|ChemDiv|Chemieliva Pharmaceu",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
15742132,Tert-Butyl (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)carbamate,139115-92-7|tert-Butyl (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)carbamate|N-Boc-PEG3-alcohol|Boc-NH-PEG3|2-[2-(2-t-Boc-aminoethoxy)ethoxy]ethanol|BocNH-PEG3-OH|NHBoc-PEG3-OH|MFCD07357496|2-[2-(2-t-Boc-aminoethoxy]ethoxy]ethanol|2-[2-[2-(Boc-amino)ethoxy]ethoxy]ethanol|(2-[2-(2-HYDROXY-ETHOXY)-ETHOXY]-ETHYL)-CARBAMIC ACID TERT-BUTYL ESTER|tert-butyl N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]carbamate|tert-Butyl {2-[2-(2-hydroxyethoxy)ethoxy]ethyl}carbamate|{2-[2-(2-Hydroxy-ethoxy)-ethoxy]-ethyl}-carbamic acid tert-bu,249.3,C11H23NO5,77,203,-0.1,17,2,5,10,"InChI=1S/C11H23NO5/c1-11(2,3)17-10(14)12-4-6-15-8-9-16-7-5-13/h13H,4-9H2,1-3H3,(H,12,14)",CC(C)(C)OC(=O)NCCOCCOCCO,FMLOTGGIHAYZLW-UHFFFAOYSA-N,tert-butyl N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]carbamate,NULL,Classification|Names and Identifiers|Patents|Safety and Hazards,4,NULL,20070212,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Accela ChemBio Inc.|Achemica|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BioChemPartner|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|BroadPharm|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
137628622,"(2~{S},4~{R})-~{N}-[[2-[2-[4-[[4-[3-Azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]methyl]phenyl]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide","(2~{S},4~{R})-~{N}-[[2-[2-[4-[[4-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]methyl]phenyl]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide|FWZ|PROTAC 2|SCHEMBL21902917",920.1,C49H58FN9O6S,228,1630,5.3,66,5,14,16,"InChI=1S/C49H58FN9O6S/c1-30-42(66-29-53-30)33-13-14-34(26-52-45(62)39-24-35(60)28-59(39)46(63)43(48(2,3)4)54-47(64)49(50)16-17-49)41(23-33)65-22-15-31-9-11-32(12-10-31)27-57-18-20-58(21-19-57)38-25-37(55-56-44(38)51)36-7-5-6-8-40(36)61/h5-14,23,25,29,35,39,43,60-61H,15-22,24,26-28H2,1-4H3,(H2,51,56)(H,52,62)(H,54,64)/t35-,39+,43-/m1/s1",CC1=C(SC=N1)C2=CC(=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)C4(CC4)F)O)OCCC5=CC=C(C=C5)CN6CCN(CC6)C7=CC(=NN=C7N)C8=CC=CC=C8O,UTZVLJZPTDCKCT-XBPZXCMESA-N,"(2S,4R)-N-[[2-[2-[4-[[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]methyl]phenyl]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxypyrrolidine-2-carboxamide",NULL,Biomolecular Interactions and Pathways|Literature|Patents,3,NULL,20190408,Nature Chemical Biology|NCBI Structure|Protein Data Bank in Europe (PDBe)|SureChEMBL,Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development,NULL
20239,"4,7,10-Trioxa-1,13-tridecanediamine","4246-51-9|4,7,10-Trioxa-1,13-tridecanediamine|3,3'-((Oxybis(ethane-2,1-diyl))bis(oxy))bis(propan-1-amine)|Bis-NH2-C1-PEG3|Diethylene Glycol Bis(3-aminopropyl) Ether|3,3'-Oxybis(ethyleneoxy)bis(propylamine)|UNII-95W232H4RT|PROTAC Linker 24|3-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propan-1-amine|Di(3-aminopropyl) ether of diethylene glycol|DIETHYLENE GLYCOL, DI(3-AMINOPROPYL) ETHER|1-Propanamine, 3,3'-[oxybis(2,1-ethanediyloxy)]bis-|3,3'-[OXYBIS(ETHANE-2,1-DIYLOXY)]DIPROPAN-1-AMINE|95W232H4RT|3,3'-(Oxybis(2,1-et",220.31,C10H24N2O3,79.7,103,-1.4,15,2,5,12,InChI=1S/C10H24N2O3/c11-3-1-5-13-7-9-15-10-8-14-6-2-4-12/h1-12H2,C(CN)COCCOCCOCCCN,JCEZOHLWDIONSP-UHFFFAOYSA-N,3-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propan-1-amine,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,10,651631|651632|651633|651634|720516|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|7,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|BePharm Ltd.|Biosynth Carbosynth|BLD Pharm|BOC Sciences|BroadPharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|ChemIDplus|Chemieliv",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
95875,2-[2-(2-Aminoethoxy)ethoxy]ethanol,"6338-55-2|2-[2-(2-aminoethoxy)ethoxy]ethanol|2-(2-(2-Aminoethoxy)ethoxy)ethanol|Amino-PEG3-alcohol|NH2-PEG3|Ethanol, 2-[2-(2-aminoethoxy)ethoxy]-|PROTAC Linker 35|MFCD07367495|H2N-PEG3-OH|CHEMBL3092861|2-(2-(2-aminoethoxy)ethoxy)ethan-1-ol|Ethanol, 2-(2-(2-aminoethoxy)ethoxy)-|triglycolamine|NSC40760|Amino-PEG3|Amino-?PEG3-?alcohol|ACMC-209nf8|Triethylene glycol monoamine|8-Amino-3,6-dioxaoctanol|(PEO)3-MONO-AMINE|SCHEMBL313703|8-Amino-3,6-dioxaoctane-1-ol|AMY4573|DTXSID00884261|ZINC1672249|ANW-34626|BDBM50",149.19,C6H15NO3,64.7,61,-1.8,10,2,4,7,"InChI=1S/C6H15NO3/c7-1-3-9-5-6-10-4-2-8/h8H,1-7H2",C(COCCOCCO)N,ASDQMECUMYIVBG-UHFFFAOYSA-N,2-[2-(2-aminoethoxy)ethoxy]ethanol,NULL,Biological Test Results|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing,7,1056630|1056631|1056632|1056633|1056634|1056635|1056636|1056637|1056638|1056639|1056640|1056641|1056642|1056643,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|Bio",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
146681264,FKBP12 Ligand,FKBP12 Ligand|2230613-03-1|BCP31484|AP1867-2-(carboxymethoxy);PROTAC FKBP12-binding moiety 2,693.8,C38H47NO11,139,1050,6.3,50,1,11,18,"InChI=1S/C38H47NO11/c1-7-26(25-21-33(46-4)36(48-6)34(22-25)47-5)37(42)39-19-11-10-13-28(39)38(43)50-30(27-12-8-9-14-29(27)49-23-35(40)41)17-15-24-16-18-31(44-2)32(20-24)45-3/h8-9,12,14,16,18,20-22,26,28,30H,7,10-11,13,15,17,19,23H2,1-6H3,(H,40,41)",CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC=CC=C4OCC(=O)O,UYXSZUBFOQLRNQ-UHFFFAOYSA-N,"2-[2-[3-(3,4-dimethoxyphenyl)-1-[1-[2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetic acid",NULL,NULL,0,NULL,20200804,BioChemPartner,Chemical Vendors,NULL
46916268,"4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile","E3 ligase Ligand 5|4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile|1264754-13-3|1055361-35-7|PROTAC ERRalpha ligand 1|CHEMBL1671971|E3L-4133|4-[4-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-2-methoxyphenoxy]-3-(trifluoromethyl)benzonitrile|4-{4-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-2-methoxyphenoxy}-3-(trifluoromethyl)benzonitrile|4-{4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-2-methoxyphenoxy}-3-(trifluoromethyl)benzonitrile|EX-A3298|BDB",420.4,C19H11F3N2O4S,114,733,4.3,29,1,9,4,"InChI=1S/C19H11F3N2O4S/c1-27-15-7-10(8-16-17(25)24-18(26)29-16)2-5-14(15)28-13-4-3-11(9-23)6-12(13)19(20,21)22/h2-8H,1H3,(H,24,25,26)/b16-8-",COC1=C(C=CC(=C1)/C=C\\2/C(=O)NC(=O)S2)OC3=C(C=C(C=C3)C#N)C(F)(F)F,OBBIOCQFTMNSJI-PXNMLYILSA-N,"4-[4-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-2-methoxyphenoxy]-3-(trifluoromethyl)benzonitrile",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,7,569732|569733|569735|569736|569802|569803|569804|569805|569806|569807|569808|569809|569810|569811|569812|569813|569814|569815|569816|569817|569818|569819|569820|569821|569822|569823|569824|569825|569826|569827|569828|569829|569830|569831|569832|569833|569834|569835|569836|569837|569838|569839|569840|569841|569842|569843|569844|569845|569846|569847|569848|569849|569850|569851|569852|569853|569854|569855|569856|569857|569858|569859|569860|569861|569862|569863|569864|569865|569866|569867|569868|569869|569870|5,20101021,A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Achemtek|Alichem|Ambeed|Angel Pharmatech Ltd.|BindingDB|BLD Pharm|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemShuttle|Combi-Blocks|CSNpharm|DC Chemicals|DiscoveryGate|eNovation Chemicals|Excenen Pharmatech|Google Patents|MedChemexpress MCE|MolPort|MuseChem|NCBI Structure|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|Smolecule|THE BioTek|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,NULL
75253234,"4-[4-(2,4-Dioxo-thiazolidin-5-ylidenemethyl)-2-methoxy-phenoxy]-3-trifluoromethyl-benzonitrile","PROTAC ERR|A ligand 1|SCHEMBL650141|4-[4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-2-methoxyphenoxy]-3-(trifluoromethyl)benzonitrile|BCP30247|AKOS030228733|AK314283|DB-106514|4-[4-(2,4-Dioxo-thiazolidin-5-ylidenemethyl)-2-methoxy-phenoxy]-3-trifluoromethyl-benzonitrile",420.4,C19H11F3N2O4S,114,733,4.3,29,1,9,4,"InChI=1S/C19H11F3N2O4S/c1-27-15-7-10(8-16-17(25)24-18(26)29-16)2-5-14(15)28-13-4-3-11(9-23)6-12(13)19(20,21)22/h2-8H,1H3,(H,24,25,26)",COC1=C(C=CC(=C1)C=C2C(=O)NC(=O)S2)OC3=C(C=C(C=C3)C#N)C(F)(F)F,OBBIOCQFTMNSJI-UHFFFAOYSA-N,"4-[4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-2-methoxyphenoxy]-3-(trifluoromethyl)benzonitrile",NULL,Literature|Patents,2,NULL,20140708,"AKos Consulting & Solutions|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|BioChemPartner|BOC Sciences|Debye Scientific Co., Ltd|Google Patents|IBM|King Scientific|NextMove Software|PATENTSCOPE (WIPO)|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
134694956,Cl-C6-PEG4-O-CH2COOH,"Cl-C6-PEG4-O-CH2COOH|1799506-30-1|PROTAC Linker 4|AKOS037653335|HY-112496|CS-0046142|21-Chloro-3,6,9,12,15-pentaoxahenicosan-1-oic acid",370.9,C16H31ClO7,83.4,267,1.1,24,1,7,20,"InChI=1S/C16H31ClO7/c17-5-3-1-2-4-6-20-7-8-21-9-10-22-11-12-23-13-14-24-15-16(18)19/h1-15H2,(H,18,19)",C(CCCCl)CCOCCOCCOCCOCCOCC(=O)O,JKRQJQUHILRKGV-UHFFFAOYSA-N,2-[2-[2-[2-[2-(6-chlorohexoxy)ethoxy]ethoxy]ethoxy]ethoxy]acetic acid,NULL,NULL,NA,NULL,20180824,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemenu Inc.|MedChemexpress MCE|MolPort,Chemical Vendors,NULL
137628626,"(2~{S},4~{R})-~{N}-[[2-[2-[2-[2-[4-[3-Azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide","(2~{S},4~{R})-~{N}-[[2-[2-[2-[2-[4-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide|PROTAC 1|SCHEMBL21902924|FX8",918.1,C46H60FN9O8S,246,1560,3.2,65,5,16,20,"InChI=1S/C46H60FN9O8S/c1-29-39(65-28-50-29)30-9-10-31(26-49-42(59)36-24-32(57)27-56(36)43(60)40(45(2,3)4)51-44(61)46(47)11-12-46)38(23-30)64-22-21-63-20-19-62-18-17-54-13-15-55(16-14-54)35-25-34(52-53-41(35)48)33-7-5-6-8-37(33)58/h5-10,23,25,28,32,36,40,57-58H,11-22,24,26-27H2,1-4H3,(H2,48,53)(H,49,59)(H,51,61)/t32-,36+,40-/m1/s1",CC1=C(SC=N1)C2=CC(=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)C4(CC4)F)O)OCCOCCOCCN5CCN(CC5)C6=CC(=NN=C6N)C7=CC=CC=C7O,QCULBRPVCWJUKY-OUMVKTTMSA-N,"(2S,4R)-N-[[2-[2-[2-[2-[4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxypyrrolidine-2-carboxamide",NULL,Biomolecular Interactions and Pathways|Literature|Patents,3,NULL,20190408,Nature Chemical Biology|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL,Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development,NULL
8200,Tetraethylene glycol,"TETRAETHYLENE GLYCOL|112-60-7|Tetraglycol|2,2'-((Oxybis(ethane-2,1-diyl))bis(oxy))diethanol|3,6,9-Trioxaundecane-1,11-diol|HI-Dry|Carbitol, diethyl|Ethanol, 2,2'-[oxybis(2,1-ethanediyloxy)]bis-|Bis[2-(2-hydroxyethoxy)ethyl] ether|PEG-4|MFCD00002879|Tetra(ethylene glycol)|3,6,9-Trioxaundecan-1,11-diol|NSC 1262|2,2'-[oxybis(ethane-2,1-diyloxy)]diethanol|Ethanol, 2,2'-(oxybis(ethyleneoxy))di-|PROTAC Linker 18|2,2'-[oxybis(2,1-ethanediyloxy)]diethanol|HO-PEG4-OH|2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethanol|Te",194.23,C8H18O5,68.2,78.6,-1.6,13,2,5,10,"InChI=1S/C8H18O5/c9-1-3-11-5-7-13-8-6-12-4-2-10/h9-10H,1-8H2",C(COCCOCCOCCO)O,UWHCKJMYHZGTIT-UHFFFAOYSA-N,2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethanol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,155|157|161|165|167|175|248|1469|1479|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|651631|651632|651633|651634|651741|651743|651749|651751|651777|651778|651838|720516|720552|720634|720635|720636|720637|720653|720659|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|74306,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|BroadPharm|ChEBI|Chem-Spac",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
70248,"1,8-Diamino-3,6-dioxaoctane","929-59-9|1,8-Diamino-3,6-dioxaoctane|Amino-PEG2-Amine|1,2-Bis(2-aminoethoxy)ethane|2,2'-(Ethylenedioxy)bis(ethylamine)|Bis-NH2-PEG2|Ethylene Glycol Bis(2-aminoethyl) Ether|3,6-Dioxaoctamethylenediamine|2,2'-[ethane-1,2-diylbis(oxy)]diethanamine|3,6-Dioxaoctane-1,8-diamine|UNII-R41ZT4UF34|2,2'-(Ethane-1,2-diylbis(oxy))diethanamine|2-[2-(2-Aminoethoxy)ethoxy]ethanamine|Ethanamine, 2,2'-[1,2-ethanediylbis(oxy)]bis-|PROTAC Linker 19|H2N-PEG-NH2|R41ZT4UF34|MFCD00040474|2-[2-(2-aminoethoxy)ethoxy]ethylamine|2-[2-",148.2,C6H16N2O2,70.5,53.7,-2,10,2,4,7,InChI=1S/C6H16N2O2/c7-1-3-9-5-6-10-4-2-8/h1-8H2,C(COCCOCCN)N,IWBOPFCKHIJFMS-UHFFFAOYSA-N,2-[2-(2-aminoethoxy)ethoxy]ethanamine,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,9,248|651631|651632|651633|651634|720516|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|7432,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemica|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|BOC Sciences|Boerchem|BroadPharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemExper Chemical Dire",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
5220470,Tert-Butyl (2-(2-hydroxyethoxy)ethyl)carbamate,139115-91-6|2-(2-Boc-aminoethoxy)ethanol|tert-Butyl (2-(2-hydroxyethoxy)ethyl)carbamate|N-Boc-PEG2-alcohol|Boc-NH-PEG2|2-[2-(Boc-amino)ethoxy]ethanol|Tert-butyl N-[2-(2-hydroxyethoxy)ethyl]carbamate|MFCD04038542|PROTAC Linker 11|tert-butyl 2-(2-hydroxyethoxy)ethylcarbamate|2-[2-(Boc-amino)-ethoxy]-ethanol|2-[2-(tert-Butoxycarbonylamino)ethoxy]ethanol|tert-butyl [2-(2-hydroxyethoxy)ethyl]carbamate|BocNH-PEG2-OH|SCHEMBL674127|AMY4444|DTXSID00410988|ZINC2525355|MFCD09753879|AKOS000799085|CS-W004896|HY-W004896|,205.25,C9H19NO4,67.8,165,0.1,14,2,4,7,"InChI=1S/C9H19NO4/c1-9(2,3)14-8(12)10-4-6-13-7-5-11/h11H,4-7H2,1-3H3,(H,10,12)",CC(C)(C)OC(=O)NCCOCCO,KSFVNEXYCULLEJ-UHFFFAOYSA-N,tert-butyl N-[2-(2-hydroxyethoxy)ethyl]carbamate,NULL,Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,5,NULL,20051007,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Accela ChemBio Inc.|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Angene Chemical|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BLD Pharm|BOC Sciences|BroadPharm|Chem-Space.com Database|ChemDB|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
10911448,"11-Azido-3,6,9-trioxaundecanoic Acid","11-Azido-3,6,9-trioxaundecanoic Acid|172531-37-2|N3-PEG3-CH2COOH|Azido-PEG3-CH2CO2H|2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)acetic acid|PROTAC Linker 14|2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]acetic Acid|MFCD16295189|2-{2-[2-(2-azidoethoxy)ethoxy]ethoxy}acetic acid|Azido-PEG3-carboxylate|ACMC-209e4s|N3-PEG3-CH2CO2H|SCHEMBL13498594|AMY4538|DTXSID70448112|ANW-22586|ZB0971|ZINC34557865|AKOS025294713|BP-23615|HY-42637|SY054116|CS-0025201|(2-[2-(2-Azidoethoxy)ethoxy]ethoxy)acetic acid",233.22,C8H15N3O5,79.4,230,0.3,16,1,7,11,"InChI=1S/C8H15N3O5/c9-11-10-1-2-14-3-4-15-5-6-16-7-8(12)13/h1-7H2,(H,12,13)",C(COCCOCCOCC(=O)O)N=[N+]=[N-],GIXBCECBLAEYKA-UHFFFAOYSA-N,2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]acetic acid,NULL,Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,5,NULL,20061026,"001Chemical|3A SpeedChemical Inc|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Acadechem|Accela ChemBio Inc.|Achemica|Activate Scientific|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Ambinter|Anward|Apexmol|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|BOC Sciences|BroadPharm|Chem-Space.com Database|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemTik|Combi-Blocks|DC Chemicals|DiscoveryGate|eNovation Chemicals|EPA DSSTox|Google Patents|IBM|iChemical Techn",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
129072807,Boc-C1-PEG2-C4-Cl,Boc-C1-PEG2-C4-Cl|PROTAC Linker 1|1835705-53-7|SCHEMBL18788322|ClCCCCCCOCCOCC(=O)OC(C)(C)C|AKOS037653333|HY-108371|CS-0028494,294.81,C14H27ClO4,44.8,226,2.9,19,0,4,13,"InChI=1S/C14H27ClO4/c1-14(2,3)19-13(16)12-18-11-10-17-9-7-5-4-6-8-15/h4-12H2,1-3H3",CC(C)(C)OC(=O)COCCOCCCCCCCl,GRFAVKLYDZBECC-UHFFFAOYSA-N,tert-butyl 2-[2-(6-chlorohexoxy)ethoxy]acetate,NULL,Names and Identifiers|Patents,2,NULL,20170804,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemenu Inc.|CSNpharm|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
129086839,Boc-C5-O-C5-O-C6-Cl,PROTAC Linker 2|Boc-C5-O-C5-O-C6-Cl|1835705-52-6|SCHEMBL18804554|AKOS037653336|ClCCCCCCOCCCCCOCCCCCC(=O)OC(C)(C)C|HY-108372|CS-0028495|tert-Butyl 6-((5-((6-chlorohexyl)oxy)pentyl)oxy)hexanoate,393,C21H41ClO4,44.8,316,4.9,26,0,4,20,"InChI=1S/C21H41ClO4/c1-21(2,3)26-20(23)14-8-6-11-17-25-19-13-7-12-18-24-16-10-5-4-9-15-22/h4-19H2,1-3H3",CC(C)(C)OC(=O)CCCCCOCCCCCOCCCCCCCl,BCFCLXINSZPNKH-UHFFFAOYSA-N,tert-butyl 6-[5-(6-chlorohexoxy)pentoxy]hexanoate,NULL,Patents,1,NULL,20170804,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemenu Inc.|DC Chemicals|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
